<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1998-07-15" modified="2020-10-07" version="231">
<accession>O00571</accession>
<accession>A8K538</accession>
<accession>B4E3E8</accession>
<accession>O15536</accession>
<name>DDX3X_HUMAN</name>
<protein>
<recommendedName>
<fullName>ATP-dependent RNA helicase DDX3X</fullName>
<ecNumber evidence="24 29 45 69 70">3.6.4.13</ecNumber>
</recommendedName>
<alternativeName>
<fullName>CAP-Rf</fullName>
</alternativeName>
<alternativeName>
<fullName>DEAD box protein 3, X-chromosomal</fullName>
</alternativeName>
<alternativeName>
<fullName>DEAD box, X isoform</fullName>
<shortName>DBX</shortName>
</alternativeName>
<alternativeName>
<fullName>Helicase-like protein 2</fullName>
<shortName>HLP2</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">DDX3X</name>
<name type="synonym" evidence="73">DBX</name>
<name type="synonym">DDX3</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1995" name="Korean J. Biochem." volume="27" first="193" last="197">
<title>Identification of a human homolog of a putative RNA helicase gene (mDEAD3) expressed in mouse erythroid cells.</title>
<authorList>
<person name="Chung J."/>
<person name="Lee S.-G."/>
<person name="Song K."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1999" name="Virology" volume="257" first="330" last="340">
<title>Hepatitis C virus core protein interacts with a human DEAD box protein DDX3.</title>
<authorList>
<person name="Owsianka A.M."/>
<person name="Patel A.H."/>
</authorList>
<dbReference type="PubMed" id="10329544"/>
<dbReference type="DOI" id="10.1006/viro.1999.9659"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH HEPATITIS C VIRUS CORE PROTEIN (MICROBIAL INFECTION)</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1997" name="Science" volume="278" first="675" last="680">
<title>Functional coherence of the human Y chromosome.</title>
<authorList>
<person name="Lahn B.T."/>
<person name="Page D.C."/>
</authorList>
<dbReference type="PubMed" id="9381176"/>
<dbReference type="DOI" id="10.1126/science.278.5338.675"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>ESCAPE FROM X-INACTIVATION</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2)</scope>
<source>
<tissue>Uterus</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2005" name="Nature" volume="434" first="325" last="337">
<title>The DNA sequence of the human X chromosome.</title>
<authorList>
<person name="Ross M.T."/>
<person name="Grafham D.V."/>
<person name="Coffey A.J."/>
<person name="Scherer S."/>
<person name="McLay K."/>
<person name="Muzny D."/>
<person name="Platzer M."/>
<person name="Howell G.R."/>
<person name="Burrows C."/>
<person name="Bird C.P."/>
<person name="Frankish A."/>
<person name="Lovell F.L."/>
<person name="Howe K.L."/>
<person name="Ashurst J.L."/>
<person name="Fulton R.S."/>
<person name="Sudbrak R."/>
<person name="Wen G."/>
<person name="Jones M.C."/>
<person name="Hurles M.E."/>
<person name="Andrews T.D."/>
<person name="Scott C.E."/>
<person name="Searle S."/>
<person name="Ramser J."/>
<person name="Whittaker A."/>
<person name="Deadman R."/>
<person name="Carter N.P."/>
<person name="Hunt S.E."/>
<person name="Chen R."/>
<person name="Cree A."/>
<person name="Gunaratne P."/>
<person name="Havlak P."/>
<person name="Hodgson A."/>
<person name="Metzker M.L."/>
<person name="Richards S."/>
<person name="Scott G."/>
<person name="Steffen D."/>
<person name="Sodergren E."/>
<person name="Wheeler D.A."/>
<person name="Worley K.C."/>
<person name="Ainscough R."/>
<person name="Ambrose K.D."/>
<person name="Ansari-Lari M.A."/>
<person name="Aradhya S."/>
<person name="Ashwell R.I."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Ballabio A."/>
<person name="Banerjee R."/>
<person name="Barker G.E."/>
<person name="Barlow K.F."/>
<person name="Barrett I.P."/>
<person name="Bates K.N."/>
<person name="Beare D.M."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Beck A."/>
<person name="Bethel G."/>
<person name="Blechschmidt K."/>
<person name="Brady N."/>
<person name="Bray-Allen S."/>
<person name="Bridgeman A.M."/>
<person name="Brown A.J."/>
<person name="Brown M.J."/>
<person name="Bonnin D."/>
<person name="Bruford E.A."/>
<person name="Buhay C."/>
<person name="Burch P."/>
<person name="Burford D."/>
<person name="Burgess J."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Bye J.M."/>
<person name="Carder C."/>
<person name="Carrel L."/>
<person name="Chako J."/>
<person name="Chapman J.C."/>
<person name="Chavez D."/>
<person name="Chen E."/>
<person name="Chen G."/>
<person name="Chen Y."/>
<person name="Chen Z."/>
<person name="Chinault C."/>
<person name="Ciccodicola A."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Clerc-Blankenburg K."/>
<person name="Clifford K."/>
<person name="Cobley V."/>
<person name="Cole C.G."/>
<person name="Conquer J.S."/>
<person name="Corby N."/>
<person name="Connor R.E."/>
<person name="David R."/>
<person name="Davies J."/>
<person name="Davis C."/>
<person name="Davis J."/>
<person name="Delgado O."/>
<person name="Deshazo D."/>
<person name="Dhami P."/>
<person name="Ding Y."/>
<person name="Dinh H."/>
<person name="Dodsworth S."/>
<person name="Draper H."/>
<person name="Dugan-Rocha S."/>
<person name="Dunham A."/>
<person name="Dunn M."/>
<person name="Durbin K.J."/>
<person name="Dutta I."/>
<person name="Eades T."/>
<person name="Ellwood M."/>
<person name="Emery-Cohen A."/>
<person name="Errington H."/>
<person name="Evans K.L."/>
<person name="Faulkner L."/>
<person name="Francis F."/>
<person name="Frankland J."/>
<person name="Fraser A.E."/>
<person name="Galgoczy P."/>
<person name="Gilbert J."/>
<person name="Gill R."/>
<person name="Gloeckner G."/>
<person name="Gregory S.G."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Grocock R."/>
<person name="Gu Y."/>
<person name="Gwilliam R."/>
<person name="Hamilton C."/>
<person name="Hart E.A."/>
<person name="Hawes A."/>
<person name="Heath P.D."/>
<person name="Heitmann K."/>
<person name="Hennig S."/>
<person name="Hernandez J."/>
<person name="Hinzmann B."/>
<person name="Ho S."/>
<person name="Hoffs M."/>
<person name="Howden P.J."/>
<person name="Huckle E.J."/>
<person name="Hume J."/>
<person name="Hunt P.J."/>
<person name="Hunt A.R."/>
<person name="Isherwood J."/>
<person name="Jacob L."/>
<person name="Johnson D."/>
<person name="Jones S."/>
<person name="de Jong P.J."/>
<person name="Joseph S.S."/>
<person name="Keenan S."/>
<person name="Kelly S."/>
<person name="Kershaw J.K."/>
<person name="Khan Z."/>
<person name="Kioschis P."/>
<person name="Klages S."/>
<person name="Knights A.J."/>
<person name="Kosiura A."/>
<person name="Kovar-Smith C."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leversha M."/>
<person name="Lewis L."/>
<person name="Liu W."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Loulseged H."/>
<person name="Loveland J.E."/>
<person name="Lovell J.D."/>
<person name="Lozado R."/>
<person name="Lu J."/>
<person name="Lyne R."/>
<person name="Ma J."/>
<person name="Maheshwari M."/>
<person name="Matthews L.H."/>
<person name="McDowall J."/>
<person name="McLaren S."/>
<person name="McMurray A."/>
<person name="Meidl P."/>
<person name="Meitinger T."/>
<person name="Milne S."/>
<person name="Miner G."/>
<person name="Mistry S.L."/>
<person name="Morgan M."/>
<person name="Morris S."/>
<person name="Mueller I."/>
<person name="Mullikin J.C."/>
<person name="Nguyen N."/>
<person name="Nordsiek G."/>
<person name="Nyakatura G."/>
<person name="O'dell C.N."/>
<person name="Okwuonu G."/>
<person name="Palmer S."/>
<person name="Pandian R."/>
<person name="Parker D."/>
<person name="Parrish J."/>
<person name="Pasternak S."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Pearson D.M."/>
<person name="Pelan S.E."/>
<person name="Perez L."/>
<person name="Porter K.M."/>
<person name="Ramsey Y."/>
<person name="Reichwald K."/>
<person name="Rhodes S."/>
<person name="Ridler K.A."/>
<person name="Schlessinger D."/>
<person name="Schueler M.G."/>
<person name="Sehra H.K."/>
<person name="Shaw-Smith C."/>
<person name="Shen H."/>
<person name="Sheridan E.M."/>
<person name="Shownkeen R."/>
<person name="Skuce C.D."/>
<person name="Smith M.L."/>
<person name="Sotheran E.C."/>
<person name="Steingruber H.E."/>
<person name="Steward C.A."/>
<person name="Storey R."/>
<person name="Swann R.M."/>
<person name="Swarbreck D."/>
<person name="Tabor P.E."/>
<person name="Taudien S."/>
<person name="Taylor T."/>
<person name="Teague B."/>
<person name="Thomas K."/>
<person name="Thorpe A."/>
<person name="Timms K."/>
<person name="Tracey A."/>
<person name="Trevanion S."/>
<person name="Tromans A.C."/>
<person name="d'Urso M."/>
<person name="Verduzco D."/>
<person name="Villasana D."/>
<person name="Waldron L."/>
<person name="Wall M."/>
<person name="Wang Q."/>
<person name="Warren J."/>
<person name="Warry G.L."/>
<person name="Wei X."/>
<person name="West A."/>
<person name="Whitehead S.L."/>
<person name="Whiteley M.N."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams G."/>
<person name="Williams L."/>
<person name="Williamson A."/>
<person name="Williamson H."/>
<person name="Wilming L."/>
<person name="Woodmansey R.L."/>
<person name="Wray P.W."/>
<person name="Yen J."/>
<person name="Zhang J."/>
<person name="Zhou J."/>
<person name="Zoghbi H."/>
<person name="Zorilla S."/>
<person name="Buck D."/>
<person name="Reinhardt R."/>
<person name="Poustka A."/>
<person name="Rosenthal A."/>
<person name="Lehrach H."/>
<person name="Meindl A."/>
<person name="Minx P.J."/>
<person name="Hillier L.W."/>
<person name="Willard H.F."/>
<person name="Wilson R.K."/>
<person name="Waterston R.H."/>
<person name="Rice C.M."/>
<person name="Vaudin M."/>
<person name="Coulson A."/>
<person name="Nelson D.L."/>
<person name="Weinstock G."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Gibbs R.A."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="15772651"/>
<dbReference type="DOI" id="10.1038/nature03440"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Skin</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2000" name="J. Exp. Med." volume="191" first="2083" last="2092">
<title>An N-acetylated natural ligand of human histocompatibility leukocyte antigen (HLA)-B39. Classical major histocompatibility complex class I proteins bind peptides with a blocked NH(2) terminus in vivo.</title>
<authorList>
<person name="Yaguee J."/>
<person name="Alvarez I."/>
<person name="Rognan D."/>
<person name="Ramos M."/>
<person name="Vazquez J."/>
<person name="Lopez de Castro J.A."/>
</authorList>
<dbReference type="PubMed" id="10859333"/>
<dbReference type="DOI" id="10.1084/jem.191.12.2083"/>
</citation>
<scope>PROTEIN SEQUENCE OF 2-10</scope>
<scope>ACETYLATION AT SER-2</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2003" name="Nature" volume="426" first="570" last="574">
<title>Proteomic characterization of the human centrosome by protein correlation profiling.</title>
<authorList>
<person name="Andersen J.S."/>
<person name="Wilkinson C.J."/>
<person name="Mayor T."/>
<person name="Mortensen P."/>
<person name="Nigg E.A."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="14654843"/>
<dbReference type="DOI" id="10.1038/nature02166"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Lymphoblast</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="Cell" volume="119" first="381" last="392">
<title>Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function.</title>
<authorList>
<person name="Yedavalli V.S."/>
<person name="Neuveut C."/>
<person name="Chi Y.-H."/>
<person name="Kleiman L."/>
<person name="Jeang K.-T."/>
</authorList>
<dbReference type="PubMed" id="15507209"/>
<dbReference type="DOI" id="10.1016/j.cell.2004.09.029"/>
</citation>
<scope>FUNCTION</scope>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>INTERACTION WITH XPO1</scope>
<scope>INTERACTION WITH HIV-1 PROTEIN REV (MICROBIAL INFECTION)</scope>
<scope>MUTAGENESIS OF LYS-230 AND SER-382</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2004" name="Hum. Mol. Genet." volume="13" first="2333" last="2341">
<title>The AZFa gene DBY (DDX3Y) is widely transcribed but the protein is limited to the male germ cells by translation control.</title>
<authorList>
<person name="Ditton H.J."/>
<person name="Zimmer J."/>
<person name="Kamp C."/>
<person name="Rajpert-De Meyts E."/>
<person name="Vogt P.H."/>
</authorList>
<dbReference type="PubMed" id="15294876"/>
<dbReference type="DOI" id="10.1093/hmg/ddh240"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2005" name="Nat. Biotechnol." volume="23" first="94" last="101">
<title>Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.</title>
<authorList>
<person name="Rush J."/>
<person name="Moritz A."/>
<person name="Lee K.A."/>
<person name="Guo A."/>
<person name="Goss V.L."/>
<person name="Spek E.J."/>
<person name="Zhang H."/>
<person name="Zha X.-M."/>
<person name="Polakiewicz R.D."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="15592455"/>
<dbReference type="DOI" id="10.1038/nbt1046"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2006" name="Cancer Res." volume="66" first="6579" last="6588">
<title>DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor.</title>
<authorList>
<person name="Chao C.H."/>
<person name="Chen C.M."/>
<person name="Cheng P.L."/>
<person name="Shih J.W."/>
<person name="Tsou A.P."/>
<person name="Lee Y.H."/>
</authorList>
<dbReference type="PubMed" id="16818630"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-05-2415"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH SP1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>MUTAGENESIS OF GLU-348 AND 382-SER--THR-384</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="Oncogene" volume="25" first="1991" last="2003">
<title>DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control.</title>
<authorList>
<person name="Chang P.C."/>
<person name="Chi C.W."/>
<person name="Chau G.Y."/>
<person name="Li F.Y."/>
<person name="Tsai Y.H."/>
<person name="Wu J.C."/>
<person name="Wu Lee Y.H."/>
</authorList>
<dbReference type="PubMed" id="16301996"/>
<dbReference type="DOI" id="10.1038/sj.onc.1209239"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2007" name="Proteins" volume="67" first="1128" last="1137">
<title>Human DEAD-box ATPase DDX3 shows a relaxed nucleoside substrate specificity.</title>
<authorList>
<person name="Franca R."/>
<person name="Belfiore A."/>
<person name="Spadari S."/>
<person name="Maga G."/>
</authorList>
<dbReference type="PubMed" id="17357160"/>
<dbReference type="DOI" id="10.1002/prot.21433"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2007" name="RNA" volume="13" first="116" last="128">
<title>Protein composition of human mRNPs spliced in vitro and differential requirements for mRNP protein recruitment.</title>
<authorList>
<person name="Merz C."/>
<person name="Urlaub H."/>
<person name="Will C.L."/>
<person name="Luhrmann R."/>
</authorList>
<dbReference type="PubMed" id="17095540"/>
<dbReference type="DOI" id="10.1261/rna.336807"/>
</citation>
<scope>ASSOCIATION WITH MRNPS</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2008" name="Cell Death Differ." volume="15" first="1887" last="1900">
<title>Identification of an antiapoptotic protein complex at death receptors.</title>
<authorList>
<person name="Sun M."/>
<person name="Song L."/>
<person name="Li Y."/>
<person name="Zhou T."/>
<person name="Jope R.S."/>
</authorList>
<dbReference type="PubMed" id="18846110"/>
<dbReference type="DOI" id="10.1038/cdd.2008.124"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH FAS; GSK3A; GSK3B; TNFRSF10A AND TNFRSF10B</scope>
<scope>CLEAVAGE BY CASPASES</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2008" name="EMBO J." volume="27" first="2135" last="2146">
<title>The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response.</title>
<authorList>
<person name="Soulat D."/>
<person name="Burckstummer T."/>
<person name="Westermayer S."/>
<person name="Goncalves A."/>
<person name="Bauch A."/>
<person name="Stefanovic A."/>
<person name="Hantschel O."/>
<person name="Bennett K.L."/>
<person name="Decker T."/>
<person name="Superti-Furga G."/>
</authorList>
<dbReference type="PubMed" id="18583960"/>
<dbReference type="DOI" id="10.1038/emboj.2008.126"/>
</citation>
<scope>FUNCTION</scope>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>PHOSPHORYLATION AT SER-181; SER-183; SER-240; SER-269; SER-429; THR-438; SER-442; SER-456; SER-520; THR-542 AND SER-543</scope>
<scope>MUTAGENESIS OF SER-181; SER-183; LYS-230; SER-240; SER-269; SER-429; THR-438; SER-442; SER-456 AND SER-520</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2008" name="EMBO J." volume="27" first="2147" last="2157">
<title>Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activation.</title>
<authorList>
<person name="Schroder M."/>
<person name="Baran M."/>
<person name="Bowie A.G."/>
</authorList>
<dbReference type="PubMed" id="18636090"/>
<dbReference type="DOI" id="10.1038/emboj.2008.143"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH VACV PROTEIN K7 (MICROBIAL INFECTION) AND IKBKE</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF LYS-230</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2008" name="Hum. Mol. Genet." volume="17" first="3055" last="3074">
<title>TDRD3, a novel Tudor domain-containing protein, localizes to cytoplasmic stress granules.</title>
<authorList>
<person name="Goulet I."/>
<person name="Boisvenue S."/>
<person name="Mokas S."/>
<person name="Mazroui R."/>
<person name="Cote J."/>
</authorList>
<dbReference type="PubMed" id="18632687"/>
<dbReference type="DOI" id="10.1093/hmg/ddn203"/>
</citation>
<scope>INTERACTION WITH TDRD3</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2008" name="Mol. Biol. Cell" volume="19" first="3847" last="3858">
<title>The DEAD-box RNA helicase DDX3 associates with export messenger ribonucleoproteins as well as tip-associated protein and participates in translational control.</title>
<authorList>
<person name="Lai M.C."/>
<person name="Lee Y.H."/>
<person name="Tarn W.Y."/>
</authorList>
<dbReference type="PubMed" id="18596238"/>
<dbReference type="DOI" id="10.1091/mbc.e07-12-1264"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH EIF4A1; EIF2S1; NXF1 AND PABPC1</scope>
<scope>ASSOCIATION WITH MRNPS</scope>
<scope>MUTAGENESIS OF SER-382</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2008" name="Nucleic Acids Res." volume="36" first="4708" last="4718">
<title>Human DDX3 functions in translation and interacts with the translation initiation factor eIF3.</title>
<authorList>
<person name="Lee C.S."/>
<person name="Dias A.P."/>
<person name="Jedrychowski M."/>
<person name="Patel A.H."/>
<person name="Hsu J.L."/>
<person name="Reed R."/>
</authorList>
<dbReference type="PubMed" id="18628297"/>
<dbReference type="DOI" id="10.1093/nar/gkn454"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH EIF3B</scope>
<scope>ASSOCIATION WITH THE EIF-3 COMPLEX</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2008" name="Oncogene" volume="27" first="700" last="714">
<title>Candidate tumor suppressor DDX3 RNA helicase specifically represses cap-dependent translation by acting as an eIF4E inhibitory protein.</title>
<authorList>
<person name="Shih J.W."/>
<person name="Tsai T.Y."/>
<person name="Chao C.H."/>
<person name="Wu Lee Y.H."/>
</authorList>
<dbReference type="PubMed" id="17667941"/>
<dbReference type="DOI" id="10.1038/sj.onc.1210687"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH EIF4E</scope>
<scope>MUTAGENESIS OF TYR-38; LEU-43; GLU-348 AND 382-SER--THR-384</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2008" name="Oncogene" volume="27" first="3912" last="3922">
<title>Oncogenic role of DDX3 in breast cancer biogenesis.</title>
<authorList>
<person name="Botlagunta M."/>
<person name="Vesuna F."/>
<person name="Mironchik Y."/>
<person name="Raman A."/>
<person name="Lisok A."/>
<person name="Winnard P. Jr."/>
<person name="Mukadam S."/>
<person name="Van Diest P."/>
<person name="Chen J.H."/>
<person name="Farabaugh P."/>
<person name="Patel A.H."/>
<person name="Raman V."/>
</authorList>
<dbReference type="PubMed" id="18264132"/>
<dbReference type="DOI" id="10.1038/onc.2008.33"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-612</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2009" name="RNA" volume="15" first="104" last="115">
<title>Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs.</title>
<authorList>
<person name="Weidensdorfer D."/>
<person name="Stoehr N."/>
<person name="Baude A."/>
<person name="Lederer M."/>
<person name="Koehn M."/>
<person name="Schierhorn A."/>
<person name="Buchmeier S."/>
<person name="Wahle E."/>
<person name="Huettelmaiery S."/>
</authorList>
<dbReference type="PubMed" id="19029303"/>
<dbReference type="DOI" id="10.1261/rna.1175909"/>
</citation>
<scope>IDENTIFICATION IN AN MRNP COMPLEX</scope>
<scope>INTERACTION WITH IGF2BP1</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-118</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2010" name="Eur. J. Immunol." volume="40" first="940" last="948">
<title>DEAD/H BOX 3 (DDX3) helicase binds the RIG-I adaptor IPS-1 to up-regulate IFN-beta-inducing potential.</title>
<authorList>
<person name="Oshiumi H."/>
<person name="Sakai K."/>
<person name="Matsumoto M."/>
<person name="Seya T."/>
</authorList>
<dbReference type="PubMed" id="20127681"/>
<dbReference type="DOI" id="10.1002/eji.200940203"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH IFIH1; MAVS AND DDX58</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2010" name="J. Gen. Virol." volume="91" first="2080" last="2090">
<title>Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3.</title>
<authorList>
<person name="Yu S."/>
<person name="Chen J."/>
<person name="Wu M."/>
<person name="Chen H."/>
<person name="Kato N."/>
<person name="Yuan Z."/>
</authorList>
<dbReference type="PubMed" id="20375222"/>
<dbReference type="DOI" id="10.1099/vir.0.020552-0"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH TBK1</scope>
<scope>INTERACTION WITH HEPATITIS B VIRUS POLYMERASE (MICROBIAL INFECTION)</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2010" name="Mol. Cell. Biol." volume="30" first="5444" last="5453">
<title>DDX3 regulates cell growth through translational control of cyclin E1.</title>
<authorList>
<person name="Lai M.C."/>
<person name="Chang W.C."/>
<person name="Shieh S.Y."/>
<person name="Tarn W.Y."/>
</authorList>
<dbReference type="PubMed" id="20837705"/>
<dbReference type="DOI" id="10.1128/mcb.00560-10"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF SER-382</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2010" name="PLoS ONE" volume="5" first="E14258" last="E14258">
<title>Hepatitis C virus core protein abrogates the DDX3 function that enhances IPS-1-mediated IFN-beta induction.</title>
<authorList>
<person name="Oshiumi H."/>
<person name="Ikeda M."/>
<person name="Matsumoto M."/>
<person name="Watanabe A."/>
<person name="Takeuchi O."/>
<person name="Akira S."/>
<person name="Kato N."/>
<person name="Shimotohno K."/>
<person name="Seya T."/>
</authorList>
<dbReference type="PubMed" id="21170385"/>
<dbReference type="DOI" id="10.1371/journal.pone.0014258"/>
</citation>
<scope>FUNCTION</scope>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>RNA-BINDING</scope>
<scope>INTERACTION WITH MAVS</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2010" name="PLoS Pathog." volume="6" first="E1000986" last="E1000986">
<title>Hepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: implications for immune evasion.</title>
<authorList>
<person name="Wang H."/>
<person name="Ryu W.S."/>
</authorList>
<dbReference type="PubMed" id="20657822"/>
<dbReference type="DOI" id="10.1371/journal.ppat.1000986"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH IKBKE</scope>
<scope>INTERACTION WITH HEPATITIS B VIRUS POLYMERASE (MICROBIAL INFECTION)</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="34">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2011" name="PLoS ONE" volume="6" first="E19810" last="E19810">
<title>A motif unique to the human DEAD-box protein DDX3 is important for nucleic acid binding, ATP hydrolysis, RNA/DNA unwinding and HIV-1 replication.</title>
<authorList>
<person name="Garbelli A."/>
<person name="Beermann S."/>
<person name="Di Cicco G."/>
<person name="Dietrich U."/>
<person name="Maga G."/>
</authorList>
<dbReference type="PubMed" id="21589879"/>
<dbReference type="DOI" id="10.1371/journal.pone.0019810"/>
</citation>
<scope>FUNCTION</scope>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>MUTAGENESIS OF LYS-230 AND 347-ASP--ASP-350</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2011" name="Proc. Natl. Acad. Sci. U.S.A." volume="108" first="12007" last="12012">
<title>DEAD-box RNA helicase Belle/DDX3 and the RNA interference pathway promote mitotic chromosome segregation.</title>
<authorList>
<person name="Pek J.W."/>
<person name="Kai T."/>
</authorList>
<dbReference type="PubMed" id="21730191"/>
<dbReference type="DOI" id="10.1073/pnas.1106245108"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NCAPH</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-131</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2012" name="Biochem. J." volume="441" first="119" last="129">
<title>Critical roles of RNA helicase DDX3 and its interactions with eIF4E/PABP1 in stress granule assembly and stress response.</title>
<authorList>
<person name="Shih J.W."/>
<person name="Wang W.T."/>
<person name="Tsai T.Y."/>
<person name="Kuo C.Y."/>
<person name="Li H.K."/>
<person name="Wu Lee Y.H."/>
</authorList>
<dbReference type="PubMed" id="21883093"/>
<dbReference type="DOI" id="10.1042/bj20110739"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH EIF4E AND PABPC1</scope>
<scope>MUTAGENESIS OF LEU-43; GLU-348 AND 382-SER--THR-384</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2012" name="J. Cell. Biochem." volume="113" first="985" last="996">
<title>The DEAD-box RNA helicase DDX3 interacts with DDX5, co-localizes with it in the cytoplasm during the G2/M phase of the cycle, and affects its shuttling during mRNP export.</title>
<authorList>
<person name="Choi Y.J."/>
<person name="Lee S.G."/>
</authorList>
<dbReference type="PubMed" id="22034099"/>
<dbReference type="DOI" id="10.1002/jcb.23428"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH DDX5</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="M111.015131" last="M111.015131">
<title>Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features.</title>
<authorList>
<person name="Bienvenut W.V."/>
<person name="Sumpton D."/>
<person name="Martinez A."/>
<person name="Lilla S."/>
<person name="Espagne C."/>
<person name="Meinnel T."/>
<person name="Giglione C."/>
</authorList>
<dbReference type="PubMed" id="22223895"/>
<dbReference type="DOI" id="10.1074/mcp.m111.015131"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2012" name="Nucleic Acids Res." volume="40" first="4998" last="5011">
<title>The DEAD-box helicase DDX3 supports the assembly of functional 80S ribosomes.</title>
<authorList>
<person name="Geissler R."/>
<person name="Golbik R.P."/>
<person name="Behrens S.E."/>
</authorList>
<dbReference type="PubMed" id="22323517"/>
<dbReference type="DOI" id="10.1093/nar/gks070"/>
</citation>
<scope>FUNCTION</scope>
<scope>ASSOCIATION WITH THE RIBOSOME SMALL SUBUNIT</scope>
<scope>INTERACTION WITH EIF2S1; EIF3C AND IGF2BP1/2</scope>
<scope>ASSOCIATION WITH THE EIF-3 COMPLEX</scope>
<scope>MUTAGENESIS OF TYR-200; GLN-207; LYS-230; ASP-347 AND GLU-348</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2012" name="EMBO J." volume="31" first="3745" last="3756">
<title>DEAD-box protein DDX3 associates with eIF4F to promote translation of selected mRNAs.</title>
<authorList>
<person name="Soto-Rifo R."/>
<person name="Rubilar P.S."/>
<person name="Limousin T."/>
<person name="de Breyne S."/>
<person name="Decimo D."/>
<person name="Ohlmann T."/>
</authorList>
<dbReference type="PubMed" id="22872150"/>
<dbReference type="DOI" id="10.1038/emboj.2012.220"/>
</citation>
<scope>FUNCTION</scope>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>RNA-BINDING</scope>
<scope>INTERACTION WITH EIF4G1 AND PABPC1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF TYR-38; LEU-43; GLN-207; LYS-230; GLU-348 AND SER-382</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82; SER-86; SER-90; SER-594 AND SER-605</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="44">
<citation type="journal article" date="2013" name="Mol. Cell. Biol." volume="33" first="2004" last="2015">
<title>Human DEAD box helicase 3 couples IkappaB kinase epsilon to interferon regulatory factor 3 activation.</title>
<authorList>
<person name="Gu L."/>
<person name="Fullam A."/>
<person name="Brennan R."/>
<person name="Schroder M."/>
</authorList>
<dbReference type="PubMed" id="23478265"/>
<dbReference type="DOI" id="10.1128/mcb.01603-12"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH IKBKE AND IRF3</scope>
<scope>PHOSPHORYLATION AT SER-102</scope>
<scope>MUTAGENESIS OF SER-71; 82-SER-SER-83; SER-102 AND SER-152</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2013" name="Science" volume="339" first="1436" last="1441">
<title>RNA helicase DDX3 is a regulatory subunit of casein kinase 1 in Wnt-beta-catenin signaling.</title>
<authorList>
<person name="Cruciat C.M."/>
<person name="Dolde C."/>
<person name="de Groot R.E."/>
<person name="Ohkawara B."/>
<person name="Reinhard C."/>
<person name="Korswagen H.C."/>
<person name="Niehrs C."/>
</authorList>
<dbReference type="PubMed" id="23413191"/>
<dbReference type="DOI" id="10.1126/science.1231499"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CSNK1E</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF GLU-348 AND 382-SER--THR-384</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-183</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="47">
<citation type="journal article" date="2014" name="Mol. Cell. Proteomics" volume="13" first="372" last="387">
<title>Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.</title>
<authorList>
<person name="Guo A."/>
<person name="Gu H."/>
<person name="Zhou J."/>
<person name="Mulhern D."/>
<person name="Wang Y."/>
<person name="Lee K.A."/>
<person name="Yang V."/>
<person name="Aguiar M."/>
<person name="Kornhauser J."/>
<person name="Jia X."/>
<person name="Ren J."/>
<person name="Beausoleil S.A."/>
<person name="Silva J.C."/>
<person name="Vemulapalli V."/>
<person name="Bedford M.T."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="24129315"/>
<dbReference type="DOI" id="10.1074/mcp.o113.027870"/>
</citation>
<scope>METHYLATION [LARGE SCALE ANALYSIS] AT ARG-592; ARG-617 AND ARG-632</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Colon carcinoma</tissue>
</source>
</reference>
<reference key="48">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-215</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2015" name="Mol. Cell. Biol." volume="35" first="2918" last="2931">
<title>The DHX33 RNA Helicase Promotes mRNA Translation Initiation.</title>
<authorList>
<person name="Zhang Y."/>
<person name="You J."/>
<person name="Wang X."/>
<person name="Weber J."/>
</authorList>
<dbReference type="PubMed" id="26100019"/>
<dbReference type="DOI" id="10.1128/mcb.00315-15"/>
</citation>
<scope>INTERACTION WITH DHX33</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2015" name="PLoS ONE" volume="10" first="E0128558" last="E0128558">
<title>Identification of Novel Proteins Co-Purifying with Cockayne Syndrome Group B (CSB) Reveals Potential Roles for CSB in RNA Metabolism and Chromatin Dynamics.</title>
<authorList>
<person name="Nicolai S."/>
<person name="Filippi S."/>
<person name="Caputo M."/>
<person name="Cipak L."/>
<person name="Gregan J."/>
<person name="Ammerer G."/>
<person name="Frontini M."/>
<person name="Willems D."/>
<person name="Prantera G."/>
<person name="Balajee A.S."/>
<person name="Proietti-De-Santis L."/>
</authorList>
<dbReference type="PubMed" id="26030138"/>
<dbReference type="DOI" id="10.1371/journal.pone.0128558"/>
</citation>
<scope>INTERACTION WITH ERCC6</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2016" name="Mol. Cell" volume="63" first="865" last="876">
<title>RNA remodeling activity of DEAD box proteins tuned by protein concentration, RNA length, and ATP.</title>
<authorList>
<person name="Kim Y."/>
<person name="Myong S."/>
</authorList>
<dbReference type="PubMed" id="27546789"/>
<dbReference type="DOI" id="10.1016/j.molcel.2016.07.010"/>
</citation>
<scope>HOMOOLIGOMERIZATION</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2016" name="Antiviral Res." volume="131" first="49" last="60">
<title>Venezuelan equine encephalitis virus non-structural protein 3 (nsP3) interacts with RNA helicases DDX1 and DDX3 in infected cells.</title>
<authorList>
<person name="Amaya M."/>
<person name="Brooks-Faulconer T."/>
<person name="Lark T."/>
<person name="Keck F."/>
<person name="Bailey C."/>
<person name="Raman V."/>
<person name="Narayanan A."/>
</authorList>
<dbReference type="PubMed" id="27105836"/>
<dbReference type="DOI" id="10.1016/j.antiviral.2016.04.008"/>
</citation>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>INTERACTION WITH VENEZUELAN EQUINE ENCEPHALITIS VIRUS NON-STRUCTURAL PROTEIN 3 (MICROBIAL INFECTION)</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2016" name="PLoS ONE" volume="11" first="E0164471" last="E0164471">
<title>The DEAD-Box RNA Helicase DDX3 Interacts with NF-kappaB Subunit p65 and Suppresses p65-Mediated Transcription.</title>
<authorList>
<person name="Xiang N."/>
<person name="He M."/>
<person name="Ishaq M."/>
<person name="Gao Y."/>
<person name="Song F."/>
<person name="Guo L."/>
<person name="Ma L."/>
<person name="Sun G."/>
<person name="Liu D."/>
<person name="Guo D."/>
<person name="Chen Y."/>
</authorList>
<dbReference type="PubMed" id="27736973"/>
<dbReference type="DOI" id="10.1371/journal.pone.0164471"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RELA</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF LYS-230 AND 275-THR--GLU-277</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2017" name="Biochem. J." volume="474" first="571" last="587">
<title>DDX3 directly regulates TRAF3 ubiquitination and acts as a scaffold to co-ordinate assembly of signalling complexes downstream from MAVS.</title>
<authorList>
<person name="Gu L."/>
<person name="Fullam A."/>
<person name="McCormack N."/>
<person name="Hoehn Y."/>
<person name="Schroeder M."/>
</authorList>
<dbReference type="PubMed" id="27980081"/>
<dbReference type="DOI" id="10.1042/bcj20160956"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH IKBKE; IRF3; MAVS; TBKBP1 AND TRAF3</scope>
<scope>MUTAGENESIS OF 142-PRO--GLU-144</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2017" name="Biochem. J." volume="474" first="3109" last="3120">
<title>The helicase, DDX3X, interacts with poly(A)-binding protein 1 (PABP1) and caprin-1 at the leading edge of migrating fibroblasts and is required for efficient cell spreading.</title>
<authorList>
<person name="Copsey A.C."/>
<person name="Cooper S."/>
<person name="Parker R."/>
<person name="Lineham E."/>
<person name="Lapworth C."/>
<person name="Jallad D."/>
<person name="Sweet S."/>
<person name="Morley S.J."/>
</authorList>
<dbReference type="PubMed" id="28733330"/>
<dbReference type="DOI" id="10.1042/bcj20170354"/>
</citation>
<scope>INTERACTION WITH CAPRIN1; EIF4E AND PABPC1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-215</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2017" name="Sci. Rep." volume="7" first="9411" last="9411">
<title>DDX3 localizes to the centrosome and prevents multipolar mitosis by epigenetically and translationally modulating p53 expression.</title>
<authorList>
<person name="Chen W.J."/>
<person name="Wang W.T."/>
<person name="Tsai T.Y."/>
<person name="Li H.K."/>
<person name="Lee Y.W."/>
</authorList>
<dbReference type="PubMed" id="28842590"/>
<dbReference type="DOI" id="10.1038/s41598-017-09779-w"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH TP53 AND GAMMA-TUBULIN</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2017" name="Sci. Rep." volume="7" first="13832" last="13832">
<title>DDX3 regulates endoplasmic reticulum stress-induced ATF4 expression.</title>
<authorList>
<person name="Adjibade P."/>
<person name="Grenier St-Sauveur V."/>
<person name="Bergeman J."/>
<person name="Huot M.E."/>
<person name="Khandjian E.W."/>
<person name="Mazroui R."/>
</authorList>
<dbReference type="PubMed" id="29062139"/>
<dbReference type="DOI" id="10.1038/s41598-017-14262-7"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>ASSOCIATION WITH EIF4F COMPLEX</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2017" name="Sci. Rep." volume="7" first="41452" last="41452">
<title>RNA helicase DDX3 maintains lipid homeostasis through upregulation of the microsomal triglyceride transfer protein by interacting with HNF4 and SHP.</title>
<authorList>
<person name="Tsai T.Y."/>
<person name="Wang W.T."/>
<person name="Li H.K."/>
<person name="Chen W.J."/>
<person name="Tsai Y.H."/>
<person name="Chao C.H."/>
<person name="Wu Lee Y.H."/>
</authorList>
<dbReference type="PubMed" id="28128295"/>
<dbReference type="DOI" id="10.1038/srep41452"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CREBBP; EP300; HNF4A AND NR0B2</scope>
<scope>MUTAGENESIS OF GLU-348 AND 382-SER--THR-384</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2018" name="Biochem. J." volume="475" first="3595" last="3607">
<title>DDX3 directly facilitates IKKalpha activation and regulates downstream signalling pathways.</title>
<authorList>
<person name="Fullam A."/>
<person name="Gu L."/>
<person name="Hoehn Y."/>
<person name="Schroeder M."/>
</authorList>
<dbReference type="PubMed" id="30341167"/>
<dbReference type="DOI" id="10.1042/bcj20180163"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH MAP3K14 AND CHUK</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2018" name="Eur. J. Cell Biol." volume="97" first="501" last="511">
<title>Investigating nucleo-cytoplasmic shuttling of the human DEAD-box helicase DDX3.</title>
<authorList>
<person name="Brennan R."/>
<person name="Haap-Hoff A."/>
<person name="Gu L."/>
<person name="Gautier V."/>
<person name="Long A."/>
<person name="Schroeder M."/>
</authorList>
<dbReference type="PubMed" id="30131165"/>
<dbReference type="DOI" id="10.1016/j.ejcb.2018.08.001"/>
</citation>
<scope>INTERACTION WITH XPO1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>NUCLEAR EXPORT SIGNAL</scope>
<scope>MUTAGENESIS OF 19-LEU--LEU-21</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2018" name="J. Cell Sci." volume="131">
<title>A CK1 FRET biosensor reveals that DDX3X is an essential activator of CK1epsilon.</title>
<authorList>
<person name="Dolde C."/>
<person name="Bischof J."/>
<person name="Grueter S."/>
<person name="Montada A."/>
<person name="Halekotte J."/>
<person name="Peifer C."/>
<person name="Kalbacher H."/>
<person name="Baumann U."/>
<person name="Knippschild U."/>
<person name="Suter B."/>
</authorList>
<dbReference type="PubMed" id="29222110"/>
<dbReference type="DOI" id="10.1242/jcs.207316"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CSNK1E AND CSNK1D</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT SER-429; THR-469; SER-470 AND SER-543</scope>
<scope>CHARACTERIZATION OF VARIANTS MEDULLOBLASTOMA CYS-376 AND HIS-528</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2018" name="Nat. Commun." volume="9" first="2307" last="2307">
<title>The TRPV4 channel links calcium influx to DDX3X activity and viral infectivity.</title>
<authorList>
<person name="Donate-Macian P."/>
<person name="Jungfleisch J."/>
<person name="Perez-Vilaro G."/>
<person name="Rubio-Moscardo F."/>
<person name="Peralvarez-Marin A."/>
<person name="Diez J."/>
<person name="Valverde M.A."/>
</authorList>
<dbReference type="PubMed" id="29899501"/>
<dbReference type="DOI" id="10.1038/s41467-018-04776-7"/>
</citation>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>INTERACTION WITH TRPV4</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2018" name="Nucleic Acids Res." volume="46" first="11592" last="11604">
<title>Analysis of NRAS RNA G-quadruplex binding proteins reveals DDX3X as a novel interactor of cellular G-quadruplex containing transcripts.</title>
<authorList>
<person name="Herdy B."/>
<person name="Mayer C."/>
<person name="Varshney D."/>
<person name="Marsico G."/>
<person name="Murat P."/>
<person name="Taylor C."/>
<person name="D'Santos C."/>
<person name="Tannahill D."/>
<person name="Balasubramanian S."/>
</authorList>
<dbReference type="PubMed" id="30256975"/>
<dbReference type="DOI" id="10.1093/nar/gky861"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2019" name="Cells" volume="8">
<title>Exportin-1-Dependent Nuclear Export of DEAD-box Helicase DDX3X is Central to its Role in Antiviral Immunity.</title>
<authorList>
<person name="Heaton S.M."/>
<person name="Atkinson S.C."/>
<person name="Sweeney M.N."/>
<person name="Yang S.N.Y."/>
<person name="Jans D.A."/>
<person name="Borg N.A."/>
</authorList>
<dbReference type="PubMed" id="31575075"/>
<dbReference type="DOI" id="10.3390/cells8101181"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>INTERACTION WITH XPO1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>NUCLEAR EXPORT SIGNAL</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF 12-LEU--LEU-21</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2007" name="Acta Crystallogr. F" volume="63" first="283" last="286">
<title>Expression, purification, crystallization and preliminary X-ray diffraction analysis of the DDX3 RNA helicase domain.</title>
<authorList>
<person name="Rodamilans B."/>
<person name="Montoya G."/>
</authorList>
<dbReference type="PubMed" id="17401195"/>
<dbReference type="DOI" id="10.1107/s1744309107006434"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.91 ANGSTROMS) OF 409-580</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2007" name="J. Mol. Biol." volume="372" first="150" last="159">
<title>Crystal structure of conserved domains 1 and 2 of the human DEAD-box helicase DDX3X in complex with the mononucleotide AMP.</title>
<authorList>
<person name="Hoegbom M."/>
<person name="Collins R."/>
<person name="van den Berg S."/>
<person name="Jenvert R.-M."/>
<person name="Karlberg T."/>
<person name="Kotenyova T."/>
<person name="Flores A."/>
<person name="Karlsson Hedestam G.B."/>
<person name="Schiavone L.H."/>
</authorList>
<dbReference type="PubMed" id="17631897"/>
<dbReference type="DOI" id="10.1016/j.jmb.2007.06.050"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 168-582 IN COMPLEX WITH AMP</scope>
</reference>
<reference key="69">
<citation type="journal article" date="2009" name="Structure" volume="17" first="1528" last="1537">
<title>Structural basis for targeting of human RNA helicase DDX3 by poxvirus protein K7.</title>
<authorList>
<person name="Oda S."/>
<person name="Schroder M."/>
<person name="Khan A.R."/>
</authorList>
<dbReference type="PubMed" id="19913487"/>
<dbReference type="DOI" id="10.1016/j.str.2009.09.005"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 71-90 IN COMPLEX WITH VACV PROTEIN K7 (MICROBIAL INFECTION)</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF 84-PHE-PHE-85</scope>
</reference>
<reference key="70" evidence="7">
<citation type="journal article" date="2019" name="Nat. Commun." volume="10" first="3085" last="3085">
<title>The mechanism of RNA duplex recognition and unwinding by DEAD-box helicase DDX3X.</title>
<authorList>
<person name="Song H."/>
<person name="Ji X."/>
</authorList>
<dbReference type="PubMed" id="31300642"/>
<dbReference type="DOI" id="10.1038/s41467-019-11083-2"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 132-607 IN COMPLEX WITH DSRNA</scope>
<scope>HOMODIMERIZATION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="71">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] THR-294</scope>
</reference>
<reference key="72">
<citation type="journal article" date="2015" name="Am. J. Hum. Genet." volume="97" first="343" last="352">
<title>Mutations in DDX3X are a common cause of unexplained intellectual disability with gender-specific effects on Wnt signaling.</title>
<authorList>
<consortium name="DDD Study"/>
<person name="Snijders Blok L."/>
<person name="Madsen E."/>
<person name="Juusola J."/>
<person name="Gilissen C."/>
<person name="Baralle D."/>
<person name="Reijnders M.R."/>
<person name="Venselaar H."/>
<person name="Helsmoortel C."/>
<person name="Cho M.T."/>
<person name="Hoischen A."/>
<person name="Vissers L.E."/>
<person name="Koemans T.S."/>
<person name="Wissink-Lindhout W."/>
<person name="Eichler E.E."/>
<person name="Romano C."/>
<person name="Van Esch H."/>
<person name="Stumpel C."/>
<person name="Vreeburg M."/>
<person name="Smeets E."/>
<person name="Oberndorff K."/>
<person name="van Bon B.W."/>
<person name="Shaw M."/>
<person name="Gecz J."/>
<person name="Haan E."/>
<person name="Bienek M."/>
<person name="Jensen C."/>
<person name="Loeys B.L."/>
<person name="Van Dijck A."/>
<person name="Innes A.M."/>
<person name="Racher H."/>
<person name="Vermeer S."/>
<person name="Di Donato N."/>
<person name="Rump A."/>
<person name="Tatton-Brown K."/>
<person name="Parker M.J."/>
<person name="Henderson A."/>
<person name="Lynch S.A."/>
<person name="Fryer A."/>
<person name="Ross A."/>
<person name="Vasudevan P."/>
<person name="Kini U."/>
<person name="Newbury-Ecob R."/>
<person name="Chandler K."/>
<person name="Male A."/>
<person name="Dijkstra S."/>
<person name="Schieving J."/>
<person name="Giltay J."/>
<person name="van Gassen K.L."/>
<person name="Schuurs-Hoeijmakers J."/>
<person name="Tan P.L."/>
<person name="Pediaditakis I."/>
<person name="Haas S.A."/>
<person name="Retterer K."/>
<person name="Reed P."/>
<person name="Monaghan K.G."/>
<person name="Haverfield E."/>
<person name="Natowicz M."/>
<person name="Myers A."/>
<person name="Kruer M.C."/>
<person name="Stein Q."/>
<person name="Strauss K.A."/>
<person name="Brigatti K.W."/>
<person name="Keating K."/>
<person name="Burton B.K."/>
<person name="Kim K.H."/>
<person name="Charrow J."/>
<person name="Norman J."/>
<person name="Foster-Barber A."/>
<person name="Kline A.D."/>
<person name="Kimball A."/>
<person name="Zackai E."/>
<person name="Harr M."/>
<person name="Fox J."/>
<person name="McLaughlin J."/>
<person name="Lindstrom K."/>
<person name="Haude K.M."/>
<person name="van Roozendaal K."/>
<person name="Brunner H."/>
<person name="Chung W.K."/>
<person name="Kooy R.F."/>
<person name="Pfundt R."/>
<person name="Kalscheuer V."/>
<person name="Mehta S.G."/>
<person name="Katsanis N."/>
<person name="Kleefstra T."/>
</authorList>
<dbReference type="PubMed" id="26235985"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2015.07.004"/>
</citation>
<scope>VARIANTS MRXSSB THR-214; ALA-233 DEL; VAL-233; PRO-235; PHE-300; HIS-326; GLN-351; CYS-362; CYS-376; PRO-392; PRO-417; GLY-475; SER-480; HIS-488; THR-507; ILE-509; THR-514; HIS-534; LEU-560 DEL AND LEU-568</scope>
<scope>CHARACTERIZATION OF VARIANTS MRXSSB THR-214; HIS-326; CYS-376; THR-507 AND HIS-534</scope>
<scope>INVOLVEMENT IN MRXSSB</scope>
</reference>
<comment type="function">
<text evidence="18 26 28 29 30 31 32 33 34 36 37 39 40 43 44 45 46 47 49 50 51 52 58 59 60 62 63 64 67 68 70 74">Multifunctional ATP-dependent RNA helicase (PubMed:17357160, PubMed:21589879, PubMed:31575075). The ATPase activity can be stimulated by various ribo-and deoxynucleic acids indicative for a relaxed substrate specificity (PubMed:29222110). In vitro can unwind partially double-stranded DNA with a preference for 5'-single-stranded DNA overhangs (PubMed:17357160, PubMed:21589879). Binds RNA G-quadruplex (rG4s) structures, including those located in the 5'-UTR of NRAS mRNA (PubMed:30256975). Involved in many cellular processes, which do not necessarily require its ATPase/helicase catalytic activities (Probable). Involved in transcription regulation (PubMed:16818630, PubMed:18264132). Positively regulates CDKN1A/WAF1/CIP1 transcription in an SP1-dependent manner, hence inhibits cell growth. This function requires its ATPase, but not helicase activity (PubMed:16818630, PubMed:18264132). CDKN1A up-regulation may be cell-type specific (PubMed:18264132). Binds CDH1/E-cadherin promoter and represses its transcription (PubMed:18264132). Potentiates HNF4A-mediated MTTP transcriptional activation; this function requires ATPase, but not helicase activity. Facilitates HNF4A acetylation, possibly catalyzed by CREBBP/EP300, thereby increasing the DNA-binding affinity of HNF4 to its response element. In addition, disrupts the interaction between HNF4 and SHP that forms inactive heterodimers and enhances the formation of active HNF4 homodimers. By promoting HNF4A-induced MTTP expression, may play a role in lipid homeostasis (PubMed:28128295). May positively regulate TP53 transcription (PubMed:28842590). Associates with mRNPs, predominantly with spliced mRNAs carrying an exon junction complex (EJC) (PubMed:17095540, PubMed:18596238). Involved in the regulation of translation initiation (PubMed:18628297, PubMed:17667941, PubMed:22872150). Not involved in the general process of translation, but promotes efficient translation of selected complex mRNAs, containing highly structured 5'-untranslated regions (UTR) (PubMed:20837705, PubMed:22872150). This function depends on helicase activity (PubMed:20837705, PubMed:22872150). Might facilitate translation by resolving secondary structures of 5'-UTRs during ribosome scanning (PubMed:20837705). Alternatively, may act prior to 43S ribosomal scanning and promote 43S pre-initiation complex entry to mRNAs exhibiting specific RNA motifs, by performing local remodeling of transcript structures located close to the cap moiety (PubMed:22872150). Independently of its ATPase activity, promotes the assembly of functional 80S ribosomes and disassembles from ribosomes prior to the translation elongation process (PubMed:22323517). Positively regulates the translation of cyclin E1/CCNE1 mRNA and consequently promotes G1/S-phase transition during the cell cycle (PubMed:20837705). May activate TP53 translation (PubMed:28842590). Required for endoplasmic reticulum stress-induced ATF4 mRNA translation (PubMed:29062139). Independently of its ATPase/helicase activity, enhances IRES-mediated translation; this activity requires interaction with EIF4E (PubMed:17667941, PubMed:22323517). Independently of its ATPase/helicase activity, has also been shown specifically repress cap-dependent translation, possibly by acting on translation initiation factor EIF4E (PubMed:17667941). Involved in innate immunity, acting as a viral RNA sensor. Binds viral RNAs and promotes the production of type I interferon (IFN-alpha and IFN-beta) (PubMed:31575075, PubMed:20127681, PubMed:21170385). Potentiate MAVS/DDX58-mediated induction of IFNB in early stages of infection (PubMed:20127681, PubMed:21170385). Enhances IFNB1 expression via IRF3/IRF7 pathway and participates in NFKB activation in the presence of MAVS and TBK1 (PubMed:18583960, PubMed:18636090, PubMed:21170385, PubMed:27980081, PubMed:19913487). Involved in TBK1 and IKBKE-dependent IRF3 activation leading to IFNB induction, acts as a scaffolding adapter that links IKBKE and IRF3 and coordinates their activation (PubMed:23478265). Involved in the TLR7/TLR8 signaling pathway leading to type I interferon induction, including IFNA4 production. In this context, acts as an upstream regulator of IRF7 activation by MAP3K14/NIK and CHUK/IKKA. Stimulates CHUK autophosphorylation and activation following physiological activation of the TLR7 and TLR8 pathways, leading to MAP3K14/CHUK-mediated activatory phosphorylation of IRF7 (PubMed:30341167). Also stimulates MAP3K14/CHUK-dependent NF-kappa-B signaling (PubMed:30341167). Negatively regulates TNF-induced IL6 and IL8 expression, via the NF-kappa-B pathway. May act by interacting with RELA/p65 and trapping it in the cytoplasm (PubMed:27736973). May also bind IFNB promoter; the function is independent of IRF3 (PubMed:18583960). Involved in both stress and inflammatory responses (By similarity). Independently of its ATPase/helicase activity, required for efficient stress granule assembly through its interaction with EIF4E, hence promotes survival in stressed cells (PubMed:21883093). Independently of its helicase activity, regulates NLRP3 inflammasome assembly through interaction with NLRP3 and hence promotes cell death by pyroptosis during inflammation. This function is independent of helicase activity (By similarity). Therefore DDX3X availability may be used to interpret stress signals and choose between pro-survival stress granules and pyroptotic NLRP3 inflammasomes and serve as a live-or-die checkpoint in stressed cells (By similarity). In association with GSK3A/B, negatively regulates extrinsic apoptotic signaling pathway via death domain receptors, including TNFRSF10B, slowing down the rate of CASP3 activation following death receptor stimulation (PubMed:18846110). Cleavage by caspases may inactivate DDX3X and relieve the inhibition (PubMed:18846110). Independently of its ATPase/helicase activity, allosteric activator of CSNK1E. Stimulates CSNK1E-mediated phosphorylation of DVL2, thereby involved in the positive regulation of Wnt/beta-catenin signaling pathway. Also activates CSNK1A1 and CSNK1D in vitro, but it is uncertain if these targets are physiologically relevant (PubMed:23413191, PubMed:29222110). ATPase and casein kinase-activating functions are mutually exclusive (PubMed:29222110). May be involved in mitotic chromosome segregation (PubMed:21730191).</text>
</comment>
<comment type="function">
<text evidence="44 65">(Microbial infection) Facilitates hepatitis C virus (HCV) replication (PubMed:29899501). During infection, HCV core protein inhibits the interaction between MAVS and DDX3X and therefore impairs MAVS-dependent INFB induction and might recruit DDX3X to HCV replication complex (PubMed:21170385).</text>
</comment>
<comment type="function">
<text evidence="24 32 45 50 65">(Microbial infection) Facilitates HIV-1 replication (PubMed:15507209, PubMed:18583960, PubMed:21589879, PubMed:22872150, PubMed:29899501). Acts as a cofactor for XPO1-mediated nuclear export of HIV-1 Rev RNAs (PubMed:15507209, PubMed:18583960, PubMed:29899501). This function is strongly stimulated in the presence of TBK1 and requires DDX3X ATPase activity (PubMed:18583960).</text>
</comment>
<comment type="function">
<text evidence="65">(Microbial infection) Facilitates Zika virus (ZIKV) replication.</text>
</comment>
<comment type="function">
<text evidence="65">(Microbial infection) Facilitates Dengue virus (DENV) replication.</text>
</comment>
<comment type="function">
<text evidence="56">(Microbial infection) Facilitates Venezuelan equine encephalitis virus (VEEV) replication.</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="24 29 45 69 70">
<text>ATP + H2O = ADP + H(+) + phosphate</text>
<dbReference type="Rhea" id="RHEA:13065"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:30616"/>
<dbReference type="ChEBI" id="CHEBI:43474"/>
<dbReference type="ChEBI" id="CHEBI:456216"/>
<dbReference type="EC" id="3.6.4.13"/>
</reaction>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="29">0.04 mM for ATP (in the absence of nucleic acid)</KM>
<KM evidence="29">0.03 mM for ATP (in the presence of ssDNA oligonucleoside dA200)</KM>
<KM evidence="45">0.062 mM for ATP (in the absence of nucleic acid)</KM>
<KM evidence="45">0.045 mM for ATP (in the presence of RNA oligo(rU)20)</KM>
<KM evidence="45">0.047 mM for ATP (in the presence of DNA oligo(dT)20)</KM>
<text evidence="29 45">kcat is 14 min(-1) for ATP hydrolysis in the absence of nucleic acid (PubMed:17357160). kcat is 36 min(-1) for ATP hydrolysis in the presence of ssDNA oligonucleoside dA200 (PubMed:17357160). kcat is 1.6 min(-1) for ATP hydrolysis in the absence of nucleic acid (PubMed:21589879). kcat is 3.2 min(-1) for ATP hydrolysis in the presence of RNA oligo(rU)20 (PubMed:21589879). kcat is 3.8 min(-1) for ATP hydrolysis in the presence of DNA oligo(dT)20 (PubMed:21589879).</text>
</kinetics>
</comment>
<comment type="subunit">
<text evidence="18 24 26 30 33 34 35 36 37 38 40 41 42 44 46 47 48 49 50 51 52 53 54 57 58 59 60 61 62 64 65 66 68 69 70 75 76 77 78 79">Homodimer; can bind RNA as a monomer and as a dimer/oligomer (PubMed:27546789, PubMed:31300642). Interacts with TDRD3 (PubMed:18632687). Interacts (when phosphorylated at Ser-102) with IRF3; the interaction facilitates the phosphorylation and activation of IRF3 by IKBKE (PubMed:23478265, PubMed:27980081). Directly interacts with XPO1/CRM1 (PubMed:15507209, PubMed:30131165, PubMed:31575075). The interaction with XPO1/CMR1 is dependent on the DDX3X nuclear export signal motif and XPO1 interaction with GTPase RAN in its active GTP-bound form (PubMed:31575075, PubMed:30131165). Weakly interacts with TBKBP1/SINTBAD (PubMed:27980081). Directly interacts with TRAF3; this interaction stimulates TRAF3 'Lys-63' ubiquitination (PubMed:27980081). Interacts with CSNK1E in a Wnt-dependent manner; this interaction greatly enhances CSNK1E affinity for ATP, stimulates its kinase activity and promotes CSNK1E-mediated DVL2 phosphorylation (PubMed:23413191, PubMed:29222110). In the presence of RNA, the interaction is decreased (PubMed:29222110). Also interacts with CSNK1D and stimulates its kinase activity (PubMed:23413191, PubMed:29222110). Interacts with TRPV4; this interaction is decreased when the TRPV4 channel is activated, leading to DDX3X relocalization to the nucleus (PubMed:29899501). Interacts with MAP3K14/NIK (PubMed:30341167). Directly interacts with CHUK/IKKA after physiological activation of the TLR7 and TLR8 pathways; this interaction enhances CHUK autophosphorylation (PubMed:30341167). May associate with EIF4F complex, composed of at least EIF4A, EIF4E and EIF4G1/EIF4G3 (Probable). Directly interacts with EIF4E in an RNA-independent manner; this interaction enhances EIF4E cap-binding ability (PubMed:17667941, PubMed:21883093, PubMed:28733330). Directly interacts with EIF4G1 in an RNA-independent manner (PubMed:22872150). DDX3X competes with EIF4G1 for interaction with EIF4E (PubMed:17667941, PubMed:21883093). Interacts with EIF4A1 and EIF2S1 in an RNA-independent manner (PubMed:18596238, PubMed:22323517). Associates with the eukaryotic translation initiation factor 3 (eIF-3) complex, including with EIF3B and EIF3C subunits (PubMed:18628297, PubMed:22323517). Directly interacts with IKBKE/IKKE; this interaction stimulates IKBKE activating autophosphorylation and is induced upon viral infection (PubMed:18636090, PubMed:20657822, PubMed:23478265, PubMed:27980081). Interacts with TBK1 (PubMed:20375222). Interacts with SP1; this interaction potentiates SP1-induced CDKN1A/WAF1/CIP1 transcription (PubMed:16818630). Interacts with GSK3A and GSK3B (PubMed:18846110). Interacts with several death receptors, inclusing FAS, TNFRSF10A and TNFRSF10B (PubMed:18846110). Recruited to TNFRSF10B in the absence of receptor stimulation. When TNFRSF10B is stimulated, further recruited to the receptor and cleaved by caspases. A large proteolytic fragment remains associated with TNFRSF10B (PubMed:18846110). Interacts (via C-terminus) with NXF1/TAP; this interaction may be partly involved in DDX3X nuclear export and in NXF1 localization to stress granules (PubMed:18596238). Identified in an mRNP complex, composed of at least DHX9, DDX3X, ELAVL1, HNRNPU, IGF2BP1/2, ILF3, PABPC1, PCBP2, PTBP2, STAU1, STAU2, SYNCRIP and YBX1 (PubMed:19029303). The interaction with IGF2BP1/2 is RNA-dependent (PubMed:22323517). Directly interacts with PABPC1/PABP1 in an RNA-independent manner (PubMed:18596238, PubMed:21883093, PubMed:22872150, PubMed:28733330). This interaction increases in stressed cells and decreases during cell recovery (PubMed:21883093). Interacts (via C-terminus) with MAVS/IPS-1; this interaction occurs rapidly, but transiently after Sendai virus infection (PubMed:20127681, PubMed:21170385, PubMed:27980081). The interaction potentiates MAVS-mediated IFNB induction (PubMed:20127681, PubMed:21170385). Interacts with ERCC6/CBS (PubMed:26030138). Interacts with DHX33 in an RNA-independent manner (PubMed:26100019). Interacts with DDX5 in the cytoplasm; this interaction may be more efficient when both proteins are unphosphorylated (PubMed:22034099). Interacts with DDX58/RIG-1 (PubMed:20127681). Interacts with IFIH1/MDA5 (PubMed:20127681). Interacts with NCAPH; this interaction may be important for the NCAPH localization at condensing chromosomes during mitosis (PubMed:21730191). Interacts with NLRP3 (via NACHT domain) under inflammasome-activating conditions (By similarity). Interacts with CAPRIN1 (PubMed:28733330). Interacts with HNF4A and NR0B2/SHP in an RNA-independent manner; this interaction disrupts the interaction between HNF4 and NR0B2 that forms inactive heterodimers and enhances the formation of active HNF4 homodimers (PubMed:28128295). Interacts with CREBBP/CBP (PubMed:28128295). Interacts with EP300/p300 (PubMed:28128295). Interacts with gamma-tubulin (PubMed:28842590). Interacts with phosphorylated TP53 (PubMed:28842590). Directly interacts with RELA/p65; this interaction may trap RELA in the cytoplasm, impairing nuclear relocalization upon TNF activating signals (PubMed:27736973).</text>
</comment>
<comment type="subunit">
<text evidence="41 42">(Microbial infection) Interacts with hepatitis B virus (HBV) polymerase in the cytoplasm; this interaction may inhibit DDX3X interaction with the IKBKE/TBK1 complex, and hence impair IKBKE/TBK1-mediated increase in IFNB production.</text>
</comment>
<comment type="subunit">
<text evidence="21">(Microbial infection) Directly interacts with hepatitis C virus (HCV) core protein in the cytoplasm.</text>
</comment>
<comment type="subunit">
<text evidence="36 39">(Microbial infection) Interacts with vaccinia virus (VACV) protein K7.</text>
</comment>
<comment type="subunit">
<text evidence="24">(Microbial infection) Interacts with HIV-1 protein Rev.</text>
</comment>
<comment type="subunit">
<text evidence="56">(Microbial infection) Interacts with Venezuelan equine encephalitis virus non-structural protein 3.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353779">
<id>O00571</id>
</interactant>
<interactant intactId="EBI-995350">
<id>O95786</id>
<label>DDX58</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353779">
<id>O00571</id>
</interactant>
<interactant intactId="EBI-1056162">
<id>P05198</id>
<label>EIF2S1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353779">
<id>O00571</id>
</interactant>
<interactant intactId="EBI-366696">
<id>P55884</id>
<label>EIF3B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353779">
<id>O00571</id>
</interactant>
<interactant intactId="EBI-353741">
<id>Q99613</id>
<label>EIF3C</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353779">
<id>O00571</id>
</interactant>
<interactant intactId="EBI-73711">
<id>Q04637</id>
<label>EIF4G1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353779">
<id>O00571</id>
</interactant>
<interactant intactId="EBI-307369">
<id>Q14164</id>
<label>IKBKE</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353779">
<id>O00571</id>
</interactant>
<interactant intactId="EBI-995373">
<id>Q7Z434</id>
<label>MAVS</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353779">
<id>O00571</id>
</interactant>
<interactant intactId="EBI-1046410">
<id>Q15003</id>
<label>NCAPH</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353779">
<id>O00571</id>
</interactant>
<interactant intactId="EBI-398874">
<id>Q9UBU9</id>
<label>NXF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353779">
<id>O00571</id>
</interactant>
<interactant intactId="EBI-81531">
<id>P11940</id>
<label>PABPC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353779">
<id>O00571</id>
</interactant>
<interactant intactId="EBI-8022707">
<id>P68467</id>
<label>K7R</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353779">
<id>O00571</id>
</interactant>
<interactant intactId="EBI-6164389">
<id>P04608</id>
<label>tat</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353779">
<id>O00571</id>
</interactant>
<interactant intactId="EBI-8010314">
<id>Q923J1</id>
<label>Trpm7</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353779">
<id>O00571</id>
</interactant>
<interactant intactId="EBI-6152154">
<id>P68466</id>
<label>VACWR039</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353779">
<id>O00571</id>
</interactant>
<interactant intactId="EBI-9209740">
<id>PRO_0000037517</id>
<dbReference type="UniProtKB" id="P26664"/>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353779">
<id>O00571</id>
</interactant>
<interactant intactId="EBI-6377335">
<id>PRO_0000037566</id>
<dbReference type="UniProtKB" id="P27958"/>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353779">
<id>O00571</id>
</interactant>
<interactant intactId="EBI-9254385">
<id>PRO_0000037559</id>
<dbReference type="UniProtKB" id="Q5EG65"/>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353779">
<id>O00571</id>
</interactant>
<interactant intactId="EBI-6674379">
<id>Q99IB8</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353779">
<id>O00571</id>
</interactant>
<interactant intactId="EBI-6863754">
<id>PRO_0000037541</id>
<dbReference type="UniProtKB" id="Q9WMX2"/>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="51 65">Cell membrane</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="21 24 26 33 36 48 65 66 70">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="21 24 26 33 36 40 44 46 47 48 51 56 58 61 63 64 66 68 70">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="33 35 50 63">Cytoplasm</location>
<location evidence="33 35 50 63">Stress granule</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="18">Inflammasome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="61">Cell projection</location>
<location evidence="61">Lamellipodium</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="62">Cytoplasm</location>
<location evidence="62">Cytoskeleton</location>
<location evidence="62">Microtubule organizing center</location>
<location evidence="62">Centrosome</location>
</subcellularLocation>
<text evidence="24 33 36 40 46 48 51 61 62 65 66 70">Shuttles between the nucleus and the cytosol (PubMed:15507209, PubMed:18636090, PubMed:29899501, PubMed:31575075, PubMed:30131165). Exported from the nucleus partly through the XPO1/CRM1 system and partly through NXF1/TAP (PubMed:15507209, PubMed:18636090, PubMed:18596238, PubMed:31575075, PubMed:30131165). Localizes to nuclear pores on the outer side of the nuclear membrane (PubMed:15507209). In the cytosol, partly colocalizes with mitochondria (PubMed:20127681). At G0, predominantly located in nucleus. In G1/S phase, predominantly cytoplasmic (PubMed:22034099). During prophase/prometaphase, localizes in close proximity to the condensing chromosomes (PubMed:30131165, PubMed:21730191). During telophase, localizes around the newly synthesized nuclear membrane and in the cytoplasm (PubMed:22034099). Colocalizes with TRPV4 at the plasma membrane. When TRPV4 channel is activated, intracellular Ca(2+) levels increase and the calmodulin/CAMKII pathway is activated, relocalizes to the nucleus (PubMed:29899501). WNT3A stimulation promotes DDX3 recruitment to the plasma membrane (PubMed:23413191). At the leading edge of migrating fibroblasts, colocalizes with CAPRIN1 and PABPC1 (PubMed:28733330). Localizes to centrosome throughout the cell cycle and associates with TP53 at centrosome during mitosis (PubMed:28842590). Translocates to the nucleus in response to HPIV-3 virus-mediated infection (PubMed:31575075).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>O00571-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>O00571-2</id>
<name>2</name>
<sequence type="described" ref="VSP_042830"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="23 25 26">Widely expressed (PubMed:15294876). In testis, expressed in spermatids (PubMed:15294876). Expressed in epidermis and liver (at protein level) (PubMed:16818630, PubMed:16301996).</text>
</comment>
<comment type="domain">
<text evidence="70">The C-terminus (residues 536-662) is dispensable for DDX3X trafficking.</text>
</comment>
<comment type="PTM">
<text evidence="32 48 52 64">Phosphorylated by TBK1; the phosphorylation is required for the synergistic induction of IFNB mediated by TBK1 and DDX3X (PubMed:18583960). Phosphorylated by IKBKE at Ser-102 after ssRNA viral infection; enhances the induction of INFB promoter by IRF3 (PubMed:18583960, PubMed:23478265). The cytoplasmic form is highly phosphorylated in the G1/S phase of the cell cycle and much less at G2/M (PubMed:22034099). Phosphorylation by CSNK1E may inhibit RNA-stimulated ATPase activity (PubMed:29222110).</text>
</comment>
<comment type="PTM">
<text evidence="37">Upon stimulation of death receptors, including TNFRSF10B, recruited to receptors and cleaved by caspases. Proteolytic fragments remain associated with the receptors. This cleavage presumably inactivates DDX3X anti-apoptotic function.</text>
</comment>
<comment type="disease" evidence="55">
<disease id="DI-04512">
<name>Intellectual developmental disorder, X-linked, syndromic, Snijders Blok type</name>
<acronym>MRXSSB</acronym>
<description>A disorder characterized by mild to severe intellectual disability, hypotonia, movement disorders, behavior problems, corpus callosum hypoplasia, and epilepsy. Additionally, patients manifest variable non-neurologic features such as joint hyperlaxity, skin pigmentary abnormalities, cleft lip and/or palate, hearing and visual impairment, and precocious puberty.</description>
<dbReference type="MIM" id="300958"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text evidence="71">Encoded by an chromosome X-linked gene which may escape X chromosome inactivation in females. DDX3Y, its homolog on chromosome Y, is located on the Y non-recombinant portion.</text>
</comment>
<comment type="similarity">
<text evidence="74">Belongs to the DEAD box helicase family. DDX3/DED1 subfamily.</text>
</comment>
<comment type="caution">
<text evidence="24 66 70">The role of the nuclear export signal (NES) motif in XPO1-mediated DDX3X export is controversial (PubMed:30131165, PubMed:31575075, PubMed:15507209). In one study, NES has been found dispensable for DDX3X export while the helicase domain mediates the interaction with XPO1 (PubMed:15507209). However, in two other studies, DDX3X nuclear export is dependent on both NES and Ran in its GTP-bound form while the helicase domain is not required (PubMed:30131165, PubMed:31575075).</text>
</comment>
<dbReference type="EC" id="3.6.4.13" evidence="24 29 45 69 70"/>
<dbReference type="EMBL" id="U50553">
<property type="protein sequence ID" value="AAB95637.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF061337">
<property type="protein sequence ID" value="AAC34298.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF000982">
<property type="protein sequence ID" value="AAC51829.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF000983">
<property type="protein sequence ID" value="AAC51830.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK291153">
<property type="protein sequence ID" value="BAF83842.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK304689">
<property type="protein sequence ID" value="BAG65460.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL391647">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z93015">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471141">
<property type="protein sequence ID" value="EAW59402.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471141">
<property type="protein sequence ID" value="EAW59403.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471141">
<property type="protein sequence ID" value="EAW59404.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471141">
<property type="protein sequence ID" value="EAW59405.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC011819">
<property type="protein sequence ID" value="AAH11819.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS43931.1">
<molecule id="O00571-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS55404.1">
<molecule id="O00571-2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001180345.1">
<property type="nucleotide sequence ID" value="NM_001193416.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001180346.1">
<molecule id="O00571-2"/>
<property type="nucleotide sequence ID" value="NM_001193417.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001347.3">
<molecule id="O00571-1"/>
<property type="nucleotide sequence ID" value="NM_001356.4"/>
</dbReference>
<dbReference type="PDB" id="2I4I">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=168-582"/>
</dbReference>
<dbReference type="PDB" id="2JGN">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.91"/>
<property type="chains" value="A/B/C=409-580"/>
</dbReference>
<dbReference type="PDB" id="3JRV">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="C/D/E=71-90"/>
</dbReference>
<dbReference type="PDB" id="4O2C">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="C=2-10"/>
</dbReference>
<dbReference type="PDB" id="4O2E">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.98"/>
<property type="chains" value="C/F=2-10"/>
</dbReference>
<dbReference type="PDB" id="4O2F">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="C/F=3-10"/>
</dbReference>
<dbReference type="PDB" id="4PX9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.31"/>
<property type="chains" value="A/B/C=135-407"/>
</dbReference>
<dbReference type="PDB" id="4PXA">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A=135-582"/>
</dbReference>
<dbReference type="PDB" id="5E7I">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.22"/>
<property type="chains" value="A/B/C=133-584"/>
</dbReference>
<dbReference type="PDB" id="5E7J">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.23"/>
<property type="chains" value="A=133-584"/>
</dbReference>
<dbReference type="PDB" id="5E7M">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=133-584"/>
</dbReference>
<dbReference type="PDB" id="6CZ5">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=132-607"/>
</dbReference>
<dbReference type="PDB" id="6O5F">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=132-607"/>
</dbReference>
<dbReference type="PDBsum" id="2I4I"/>
<dbReference type="PDBsum" id="2JGN"/>
<dbReference type="PDBsum" id="3JRV"/>
<dbReference type="PDBsum" id="4O2C"/>
<dbReference type="PDBsum" id="4O2E"/>
<dbReference type="PDBsum" id="4O2F"/>
<dbReference type="PDBsum" id="4PX9"/>
<dbReference type="PDBsum" id="4PXA"/>
<dbReference type="PDBsum" id="5E7I"/>
<dbReference type="PDBsum" id="5E7J"/>
<dbReference type="PDBsum" id="5E7M"/>
<dbReference type="PDBsum" id="6CZ5"/>
<dbReference type="PDBsum" id="6O5F"/>
<dbReference type="SMR" id="O00571"/>
<dbReference type="BioGRID" id="108020">
<property type="interactions" value="322"/>
</dbReference>
<dbReference type="CORUM" id="O00571"/>
<dbReference type="DIP" id="DIP-27551N"/>
<dbReference type="ELM" id="O00571"/>
<dbReference type="IntAct" id="O00571">
<property type="interactions" value="138"/>
</dbReference>
<dbReference type="MINT" id="O00571"/>
<dbReference type="STRING" id="9606.ENSP00000382840"/>
<dbReference type="BindingDB" id="O00571"/>
<dbReference type="ChEMBL" id="CHEMBL5553"/>
<dbReference type="TCDB" id="1.I.1.1.3">
<property type="family name" value="the nuclear pore complex (npc) family"/>
</dbReference>
<dbReference type="CarbonylDB" id="O00571"/>
<dbReference type="iPTMnet" id="O00571"/>
<dbReference type="MetOSite" id="O00571"/>
<dbReference type="PhosphoSitePlus" id="O00571"/>
<dbReference type="SwissPalm" id="O00571"/>
<dbReference type="BioMuta" id="DDX3X"/>
<dbReference type="REPRODUCTION-2DPAGE" id="IPI00215637"/>
<dbReference type="SWISS-2DPAGE" id="O00571"/>
<dbReference type="EPD" id="O00571"/>
<dbReference type="jPOST" id="O00571"/>
<dbReference type="MassIVE" id="O00571"/>
<dbReference type="MaxQB" id="O00571"/>
<dbReference type="PaxDb" id="O00571"/>
<dbReference type="PeptideAtlas" id="O00571"/>
<dbReference type="PRIDE" id="O00571"/>
<dbReference type="ProteomicsDB" id="47982">
<molecule id="O00571-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="47983">
<molecule id="O00571-2"/>
</dbReference>
<dbReference type="Antibodypedia" id="463">
<property type="antibodies" value="665 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000457138">
<molecule id="O00571-2"/>
<property type="protein sequence ID" value="ENSP00000392494"/>
<property type="gene ID" value="ENSG00000215301"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000478993">
<molecule id="O00571-1"/>
<property type="protein sequence ID" value="ENSP00000478443"/>
<property type="gene ID" value="ENSG00000215301"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000629496">
<molecule id="O00571-1"/>
<property type="protein sequence ID" value="ENSP00000487224"/>
<property type="gene ID" value="ENSG00000215301"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000629785">
<molecule id="O00571-1"/>
<property type="protein sequence ID" value="ENSP00000486516"/>
<property type="gene ID" value="ENSG00000215301"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000630255">
<molecule id="O00571-1"/>
<property type="protein sequence ID" value="ENSP00000486720"/>
<property type="gene ID" value="ENSG00000215301"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000644876">
<molecule id="O00571-1"/>
<property type="protein sequence ID" value="ENSP00000494040"/>
<property type="gene ID" value="ENSG00000215301"/>
</dbReference>
<dbReference type="GeneID" id="1654"/>
<dbReference type="KEGG" id="hsa:1654"/>
<dbReference type="UCSC" id="uc004dfe.4">
<molecule id="O00571-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="1654"/>
<dbReference type="DisGeNET" id="1654"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000215301.9"/>
<dbReference type="GeneCards" id="DDX3X"/>
<dbReference type="HGNC" id="HGNC:2745">
<property type="gene designation" value="DDX3X"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000215301">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="DDX3X"/>
<dbReference type="MIM" id="300160">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="300958">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O00571"/>
<dbReference type="OpenTargets" id="ENSG00000215301"/>
<dbReference type="Orphanet" id="99861">
<property type="disease" value="Precursor T-cell acute lymphoblastic leukemia"/>
</dbReference>
<dbReference type="Orphanet" id="3338">
<property type="disease" value="Toriello-Carey syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="457260">
<property type="disease" value="X-linked intellectual disability-hypotonia-movement disorder syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA27216"/>
<dbReference type="eggNOG" id="KOG0335">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000154443"/>
<dbReference type="HOGENOM" id="CLU_003041_16_3_1"/>
<dbReference type="InParanoid" id="O00571"/>
<dbReference type="KO" id="K11594"/>
<dbReference type="OrthoDB" id="595675at2759"/>
<dbReference type="PhylomeDB" id="O00571"/>
<dbReference type="TreeFam" id="TF300364"/>
<dbReference type="BRENDA" id="3.6.4.13">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="PathwayCommons" id="O00571"/>
<dbReference type="Reactome" id="R-HSA-6798695">
<property type="pathway name" value="Neutrophil degranulation"/>
</dbReference>
<dbReference type="SIGNOR" id="O00571"/>
<dbReference type="BioGRID-ORCS" id="1654">
<property type="hits" value="176 hits in 505 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="DDX3X">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="O00571"/>
<dbReference type="GeneWiki" id="DDX3X"/>
<dbReference type="GenomeRNAi" id="1654"/>
<dbReference type="Pharos" id="O00571">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:O00571"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome X"/>
</dbReference>
<dbReference type="RNAct" id="O00571">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000215301">
<property type="expression patterns" value="Expressed in substantia nigra and 251 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="O00571">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O00571">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0031252">
<property type="term" value="C:cell leading edge"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005813">
<property type="term" value="C:centrosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010494">
<property type="term" value="C:cytoplasmic stress granule"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:1904813">
<property type="term" value="C:ficolin-1-rich granule lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030027">
<property type="term" value="C:lamellipodium"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0072559">
<property type="term" value="C:NLRP3 inflammasome complex"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043186">
<property type="term" value="C:P granule"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034774">
<property type="term" value="C:secretory granule lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0016887">
<property type="term" value="F:ATPase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045296">
<property type="term" value="F:cadherin binding"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043273">
<property type="term" value="F:CTPase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003678">
<property type="term" value="F:DNA helicase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008190">
<property type="term" value="F:eukaryotic initiation factor 4E binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043015">
<property type="term" value="F:gamma-tubulin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003924">
<property type="term" value="F:GTPase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0048027">
<property type="term" value="F:mRNA 5'-UTR binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003729">
<property type="term" value="F:mRNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0017111">
<property type="term" value="F:nucleoside-triphosphatase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0008143">
<property type="term" value="F:poly(A) binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043539">
<property type="term" value="F:protein serine/threonine kinase activator activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043024">
<property type="term" value="F:ribosomal small subunit binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003724">
<property type="term" value="F:RNA helicase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035613">
<property type="term" value="F:RNA stem-loop binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033592">
<property type="term" value="F:RNA strand annealing activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031369">
<property type="term" value="F:translation initiation factor binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030154">
<property type="term" value="P:cell differentiation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0071243">
<property type="term" value="P:cellular response to arsenic-containing substance"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071470">
<property type="term" value="P:cellular response to osmotic stress"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0098586">
<property type="term" value="P:cellular response to virus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007059">
<property type="term" value="P:chromosome segregation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008625">
<property type="term" value="P:extrinsic apoptotic signaling pathway via death domain receptors"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007276">
<property type="term" value="P:gamete generation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035556">
<property type="term" value="P:intracellular signal transduction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097193">
<property type="term" value="P:intrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0055088">
<property type="term" value="P:lipid homeostasis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042256">
<property type="term" value="P:mature ribosome assembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030308">
<property type="term" value="P:negative regulation of cell growth"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043154">
<property type="term" value="P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902042">
<property type="term" value="P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2001243">
<property type="term" value="P:negative regulation of intrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901223">
<property type="term" value="P:negative regulation of NIK/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031333">
<property type="term" value="P:negative regulation of protein-containing complex assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0017148">
<property type="term" value="P:negative regulation of translation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043312">
<property type="term" value="P:neutrophil degranulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043065">
<property type="term" value="P:positive regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090263">
<property type="term" value="P:positive regulation of canonical Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030307">
<property type="term" value="P:positive regulation of cell growth"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071651">
<property type="term" value="P:positive regulation of chemokine (C-C motif) ligand 5 production"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043280">
<property type="term" value="P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1900087">
<property type="term" value="P:positive regulation of G1/S transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0032727">
<property type="term" value="P:positive regulation of interferon-alpha production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032728">
<property type="term" value="P:positive regulation of interferon-beta production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901224">
<property type="term" value="P:positive regulation of NIK/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1900227">
<property type="term" value="P:positive regulation of NLRP3 inflammasome complex assembly"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901985">
<property type="term" value="P:positive regulation of protein acetylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031954">
<property type="term" value="P:positive regulation of protein autophosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902523">
<property type="term" value="P:positive regulation of protein K63-linked ubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071902">
<property type="term" value="P:positive regulation of protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034157">
<property type="term" value="P:positive regulation of toll-like receptor 7 signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034161">
<property type="term" value="P:positive regulation of toll-like receptor 8 signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045727">
<property type="term" value="P:positive regulation of translation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0036493">
<property type="term" value="P:positive regulation of translation in response to endoplasmic reticulum stress"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045948">
<property type="term" value="P:positive regulation of translational initiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045070">
<property type="term" value="P:positive regulation of viral genome replication"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:1903608">
<property type="term" value="P:protein localization to cytoplasmic stress granule"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0009615">
<property type="term" value="P:response to virus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010501">
<property type="term" value="P:RNA secondary structure unwinding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034063">
<property type="term" value="P:stress granule assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006413">
<property type="term" value="P:translational initiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0016055">
<property type="term" value="P:Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="DisProt" id="DP02192"/>
<dbReference type="IDEAL" id="IID00232"/>
<dbReference type="InterPro" id="IPR011545">
<property type="entry name" value="DEAD/DEAH_box_helicase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR014001">
<property type="entry name" value="Helicase_ATP-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR001650">
<property type="entry name" value="Helicase_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR027417">
<property type="entry name" value="P-loop_NTPase"/>
</dbReference>
<dbReference type="InterPro" id="IPR000629">
<property type="entry name" value="RNA-helicase_DEAD-box_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR014014">
<property type="entry name" value="RNA_helicase_DEAD_Q_motif"/>
</dbReference>
<dbReference type="Pfam" id="PF00270">
<property type="entry name" value="DEAD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00271">
<property type="entry name" value="Helicase_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00487">
<property type="entry name" value="DEXDc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00490">
<property type="entry name" value="HELICc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52540">
<property type="entry name" value="SSF52540"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00039">
<property type="entry name" value="DEAD_ATP_HELICASE"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51192">
<property type="entry name" value="HELICASE_ATP_BIND_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51194">
<property type="entry name" value="HELICASE_CTER"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51195">
<property type="entry name" value="Q_MOTIF"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0966">Cell projection</keyword>
<keyword id="KW-0159">Chromosome partition</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0347">Helicase</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-1271">Inflammasome</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0991">Mental retardation</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0690">Ribosome biogenesis</keyword>
<keyword id="KW-0694">RNA-binding</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0810">Translation regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="initiator methionine" description="Removed" evidence="10 12 22">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="ATP-dependent RNA helicase DDX3X" id="PRO_0000055009">
<location>
<begin position="2"/>
<end position="662"/>
</location>
</feature>
<feature type="domain" description="Helicase ATP-binding" evidence="19">
<location>
<begin position="211"/>
<end position="403"/>
</location>
</feature>
<feature type="domain" description="Helicase C-terminal" evidence="20">
<location>
<begin position="414"/>
<end position="575"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP">
<location>
<begin position="200"/>
<end position="207"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP">
<location>
<begin position="224"/>
<end position="231"/>
</location>
</feature>
<feature type="region of interest" description="Required for TBK1 and IKBKE-dependent IFNB1 activation" evidence="36">
<location>
<begin position="2"/>
<end position="139"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with EIF4E" evidence="30">
<location>
<begin position="38"/>
<end position="44"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with VACV protein K7" evidence="39">
<location>
<begin position="81"/>
<end position="90"/>
</location>
</feature>
<feature type="region of interest" description="Involved in binding to RNA G-quadruplex" evidence="67">
<location>
<begin position="88"/>
<end position="123"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with GSK3B" evidence="37">
<location>
<begin position="100"/>
<end position="662"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with IKBKE">
<location>
<begin position="100"/>
<end position="110"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with CHUK" evidence="30">
<location>
<begin position="139"/>
<end position="172"/>
</location>
</feature>
<feature type="region of interest" description="Involved in stimulation of ATPase activity by DNA and RNA, nucleic acid binding and unwinding and HIV-1 replication">
<location>
<begin position="250"/>
<end position="259"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with HCV core protein" evidence="21">
<location>
<begin position="409"/>
<end position="662"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with NXF1" evidence="33">
<location>
<begin position="536"/>
<end position="661"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear export signal" evidence="66 70">
<location>
<begin position="12"/>
<end position="21"/>
</location>
</feature>
<feature type="short sequence motif" description="Q motif">
<location>
<begin position="180"/>
<end position="208"/>
</location>
</feature>
<feature type="short sequence motif" description="DEAD box">
<location>
<begin position="347"/>
<end position="350"/>
</location>
</feature>
<feature type="compositionally biased region" description="Gly/Ser-rich">
<location>
<begin position="582"/>
<end position="662"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylserine" evidence="10 12 22">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="18">
<location>
<position position="55"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="82"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="86"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="90"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="18">
<location>
<position position="101"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by IKKE" evidence="52">
<location>
<position position="102"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="18">
<location>
<position position="104"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="18">
<location>
<position position="110"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="9">
<location>
<position position="118"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="131"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by TBK1; in vitro" evidence="32">
<location>
<position position="181"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by TBK1" evidence="15 32">
<location>
<position position="183"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by TBK1; in vitro" evidence="32">
<location>
<position position="240"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by TBK1; in vitro" evidence="32">
<location>
<position position="269"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CSNK1E and TBK1; in vitro" evidence="32 64">
<location>
<position position="429"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by TBK1; in vitro" evidence="32">
<location>
<position position="438"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by TBK1; in vitro" evidence="32">
<location>
<position position="442"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by TBK1; in vitro" evidence="32">
<location>
<position position="456"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CSNK1E; in vitro" evidence="64">
<location>
<position position="469"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CSNK1E; in vitro" evidence="64">
<location>
<position position="470"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by TBK1; in vitro" evidence="32">
<location>
<position position="520"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by TBK1; in vitro" evidence="32">
<location>
<position position="542"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CSNK1E and TBK1; in vitro" evidence="32 64">
<location>
<position position="543"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="14">
<location>
<position position="592"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="594"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="605"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="612"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="14">
<location>
<position position="617"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="14">
<location>
<position position="632"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="16 17">
<location>
<position position="215"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_042830" evidence="72">
<original>KGRYIPPHLRNREATKG</original>
<variation>S</variation>
<location>
<begin position="35"/>
<end position="51"/>
</location>
</feature>
<feature type="sequence variant" description="In MRXSSB; loss-of-function mutation affecting regulation of Wnt signaling." id="VAR_075731" evidence="55">
<original>I</original>
<variation>T</variation>
<location>
<position position="214"/>
</location>
</feature>
<feature type="sequence variant" description="In MRXSSB; dbSNP:rs796052223." id="VAR_075732" evidence="55">
<original>A</original>
<variation>V</variation>
<location>
<position position="233"/>
</location>
</feature>
<feature type="sequence variant" description="In MRXSSB." id="VAR_075733" evidence="55">
<location>
<position position="233"/>
</location>
</feature>
<feature type="sequence variant" description="In MRXSSB; dbSNP:rs796052224." id="VAR_075734" evidence="55">
<original>L</original>
<variation>P</variation>
<location>
<position position="235"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast cancer sample; somatic mutation." id="VAR_035839" evidence="27">
<original>R</original>
<variation>T</variation>
<location>
<position position="294"/>
</location>
</feature>
<feature type="sequence variant" description="In MRXSSB." id="VAR_075735" evidence="55">
<original>V</original>
<variation>F</variation>
<location>
<position position="300"/>
</location>
</feature>
<feature type="sequence variant" description="In MRXSSB; loss-of-function mutation affecting regulation of Wnt signaling; dbSNP:rs797045025." id="VAR_075736" evidence="55">
<original>R</original>
<variation>H</variation>
<location>
<position position="326"/>
</location>
</feature>
<feature type="sequence variant" description="In MRXSSB; dbSNP:rs1057518707." id="VAR_075737" evidence="55">
<original>R</original>
<variation>Q</variation>
<location>
<position position="351"/>
</location>
</feature>
<feature type="sequence variant" description="In MRXSSB; dbSNP:rs797045026." id="VAR_075738" evidence="55">
<original>R</original>
<variation>C</variation>
<location>
<position position="362"/>
</location>
</feature>
<feature type="sequence variant" description="In MRXSSB; also found as a somatic mutation in medulloblastoma; loss of ATPase activity; increased interaction with CSNK1E in the absence of dsRNA; contrary to wild-type protein, strongly interacts with CSNK1A1 and CSNK1D in vivo; strongly increased ability to activate CSNK1E kinase activity, leading to increased DVL phosphorylation, thereby activating Wnt/beta-catenin signaling; increased RNA-binding; no effect on subcellular location; dbSNP:rs796052231." id="VAR_075739" evidence="55 64">
<original>R</original>
<variation>C</variation>
<location>
<position position="376"/>
</location>
</feature>
<feature type="sequence variant" description="In MRXSSB; dbSNP:rs796052232." id="VAR_075740" evidence="55">
<original>L</original>
<variation>P</variation>
<location>
<position position="392"/>
</location>
</feature>
<feature type="sequence variant" description="In MRXSSB; dbSNP:rs796052233." id="VAR_075741" evidence="55">
<original>Q</original>
<variation>P</variation>
<location>
<position position="417"/>
</location>
</feature>
<feature type="sequence variant" description="In MRXSSB; dbSNP:rs1064794574." id="VAR_075742" evidence="55">
<original>R</original>
<variation>G</variation>
<location>
<position position="475"/>
</location>
</feature>
<feature type="sequence variant" description="In MRXSSB." id="VAR_075743" evidence="55">
<original>R</original>
<variation>S</variation>
<location>
<position position="480"/>
</location>
</feature>
<feature type="sequence variant" description="In MRXSSB; dbSNP:rs796052235." id="VAR_075744" evidence="55">
<original>R</original>
<variation>H</variation>
<location>
<position position="488"/>
</location>
</feature>
<feature type="sequence variant" description="In MRXSSB; loss-of-function mutation affecting regulation of Wnt signaling; dbSNP:rs797045024." id="VAR_075745" evidence="55">
<original>I</original>
<variation>T</variation>
<location>
<position position="507"/>
</location>
</feature>
<feature type="sequence variant" description="In MRXSSB." id="VAR_075746" evidence="55">
<original>N</original>
<variation>I</variation>
<location>
<position position="509"/>
</location>
</feature>
<feature type="sequence variant" description="In MRXSSB; dbSNP:rs796052226." id="VAR_075747" evidence="55">
<original>I</original>
<variation>T</variation>
<location>
<position position="514"/>
</location>
</feature>
<feature type="sequence variant" description="In medulloblastoma; somatic mutation; loss of ATPase activity; interacts with CSNK1E, even in the presence of dsRNA; contrary to wild-type protein, strongly interacts with CSNK1A1 and CSNK1D in vivo; strongly increased ability to activate CSNK1E kinase activity, leading to increased DVL phosphorylation, thereby activating Wnt/beta-catenin signaling; no effect on RNA-binding, nor on subcellular location." id="VAR_083115" evidence="64">
<original>R</original>
<variation>H</variation>
<location>
<position position="528"/>
</location>
</feature>
<feature type="sequence variant" description="In MRXSSB; loss-of-function mutation affecting regulation of Wnt signaling." id="VAR_075748" evidence="55">
<original>R</original>
<variation>H</variation>
<location>
<position position="534"/>
</location>
</feature>
<feature type="sequence variant" description="In MRXSSB." id="VAR_075749" evidence="55">
<location>
<position position="560"/>
</location>
</feature>
<feature type="sequence variant" description="In MRXSSB; dbSNP:rs1057519430." id="VAR_075750" evidence="55">
<original>P</original>
<variation>L</variation>
<location>
<position position="568"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs nuclear export and interaction with XPO1/CMR1." evidence="70">
<original>LDQQFAGLDL</original>
<variation>ADQQAAGADA</variation>
<location>
<begin position="12"/>
<end position="21"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs nuclear export and interaction with XPO1/CMR1." evidence="66">
<original>LDL</original>
<variation>ADA</variation>
<location>
<begin position="19"/>
<end position="21"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired interaction with EIF4E; impaired stress granule formation, decreased repression of cap-dependent translation and decreased ability to enhance IRES-mediated translation. No effect on translation of HIV-1 RNA; when associated with A-43." evidence="30 47 50">
<original>Y</original>
<variation>A</variation>
<location>
<position position="38"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired interaction with EIF4E; decreased repression of cap-dependent translation. Fails to induce stress granule assembly and to rescue cell viability after stress. No effect on translation of HIV-1 RNA; when associated with A-38." evidence="30 47 50">
<original>L</original>
<variation>A</variation>
<location>
<position position="43"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces total phosphorylation by 60%. No effect on interaction with IKBKE." evidence="52">
<original>S</original>
<variation>A</variation>
<location>
<position position="71"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces total phosphorylation by 50%. No effect on interaction with IKBKE." evidence="52">
<original>SS</original>
<variation>AA</variation>
<location>
<begin position="82"/>
<end position="83"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with VACV protein K7, IRF3 activation and IFNB1 promoter induction." evidence="39">
<original>FF</original>
<variation>AA</variation>
<location>
<begin position="84"/>
<end position="85"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces total phosphorylation by 30%. Abolishes interaction with IRF3 and fails to enhance IFNB promoter induction. No effect on interaction with IKBKE." evidence="52">
<original>S</original>
<variation>A</variation>
<location>
<position position="102"/>
</location>
</feature>
<feature type="mutagenesis site" description="Interacts with IRF3 and enhances IFNB promoter induction." evidence="52">
<original>S</original>
<variation>D</variation>
<location>
<position position="102"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with TRAF3, reduced TRAF3 'K-63'-linked autoubiquitination." evidence="59">
<original>PSE</original>
<variation>ASA</variation>
<location>
<begin position="142"/>
<end position="144"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces total phosphorylation by 60%. No effect on interaction with IKBKE." evidence="52">
<original>S</original>
<variation>A</variation>
<location>
<position position="152"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly impairs phosphorylation by TBK1 and fails to synergize with TBK1 in IFNB1 induction; when associated with A-183; A-240 and A-269." evidence="32">
<original>S</original>
<variation>A</variation>
<location>
<position position="181"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly impairs phosphorylation by TBK1 and fails to synergize with TBK1 in IFN-beta induction; when associated with A-181; A-240 and A-269." evidence="32">
<original>S</original>
<variation>A</variation>
<location>
<position position="183"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on general translation; when associated with A-207; A-230; A-347 and A-348." evidence="49">
<original>Y</original>
<variation>A</variation>
<location>
<position position="200"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not promote the translation of HIV-1 RNA. No effect on general translation; when associated with A-200; A-230: A-347 and A-348." evidence="49 50">
<original>Q</original>
<variation>A</variation>
<location>
<position position="207"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on general translation; when associated with A-200; A-207; A-347 and A-348." evidence="49">
<original>K</original>
<variation>A</variation>
<location>
<position position="230"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of ATPase and RNA-unwinding activities. Loss of HIV-1 mRNA nuclear export. Does not promote the translation of HIV-1 RNA. No effect on IFNB1 induction. No effect on RNA-binding. Loss of inhibition of NF-kappa-B-mediated transcriptional activity." evidence="24 32 36 45 50 58">
<original>K</original>
<variation>E</variation>
<location>
<position position="230"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly impairs phosphorylation by TBK1 and fails to synergize with TBK1 in IFN-beta induction; when associated with A-181; A-183 and A-269." evidence="32">
<original>S</original>
<variation>A</variation>
<location>
<position position="240"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly impairs phosphorylation by TBK1 and fails to synergize with TBK1 in IFN-beta induction; when associated with A-181; A-183 and A-240." evidence="32">
<original>S</original>
<variation>A</variation>
<location>
<position position="269"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased NF-kappa-B-mediated transcriptional activity, contrary to wild-type which is inhibitory in this experimental setting." evidence="58">
<original>TRE</original>
<variation>RRV</variation>
<location>
<begin position="275"/>
<end position="277"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of ATPase activity." evidence="45">
<original>DEAD</original>
<variation>AEAA</variation>
<location>
<begin position="347"/>
<end position="350"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on general translation; when associated with A-200; A-207; A-230 and A-348." evidence="49">
<original>D</original>
<variation>A</variation>
<location>
<position position="347"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on general translation; when associated with A-200; A-207; A-230 and A-347." evidence="49 50">
<original>E</original>
<variation>A</variation>
<location>
<position position="348"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of both ATPase and RNA helicase activities; decreased up-regulation of CDKN1A promoter activity and HNF4A-mediated MTTP transcriptional activation; no effect on the repression of cap- and IRES-dependent translation, WNT/beta catenin signaling, nor on stress granule assembly. Does not promote the translation of HIV-1 RNA." evidence="30 47 49 50 51">
<original>E</original>
<variation>Q</variation>
<location>
<position position="348"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of RNA helicase, but not ATPase activity; no effect on the repression of cap- and IRES-dependent translation, WNT/beta catenin signaling, up-regulation of CDKN1A promoter activity, HNF4A-mediated MTTP transcriptional activation, nor on stress granule assembly." evidence="30 47 51 60">
<original>SAT</original>
<variation>AAA</variation>
<location>
<begin position="382"/>
<end position="384"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strong decrease in ATPase activity and RNA-unwinding activity. Does not promote the translation of mRNAs containing long structured 5'UTRs, including that of CCNE1. No effect on the translation of HIV-1 RNA." evidence="24 33 43 50">
<original>S</original>
<variation>L</variation>
<location>
<position position="382"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs phosphorylation by TBK1 and fails to synergize with TBK1 in IFN-beta induction; when associated with A-438; A-442; A-456 and A-520." evidence="32">
<original>S</original>
<variation>A</variation>
<location>
<position position="429"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs phosphorylation by TBK1 and fails to synergize with TBK1 in IFN-beta induction; when associated with A-429; A-442; A-456 and A-520." evidence="32">
<original>T</original>
<variation>A</variation>
<location>
<position position="438"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs phosphorylation by TBK1 and fails to synergize with TBK1 in IFN-beta induction; when associated with A-429; A-438; A-456 and A-520." evidence="32">
<original>S</original>
<variation>A</variation>
<location>
<position position="442"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs phosphorylation by TBK1 and fails to synergize with TBK1 in IFN-beta induction; when associated with A-429; A-438; A-442 and A-520." evidence="32">
<original>S</original>
<variation>A</variation>
<location>
<position position="456"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs phosphorylation by TBK1 and fails to synergize with TBK1 in IFN-beta induction; when associated with A-429; A-438; A-442 and A-456." evidence="32">
<original>S</original>
<variation>A</variation>
<location>
<position position="520"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAC51830/AAC51829." ref="3" evidence="74">
<original>K</original>
<variation>R</variation>
<location>
<position position="50"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="136"/>
<end position="138"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="144"/>
<end position="151"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="161"/>
<end position="163"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="168"/>
<end position="172"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="182"/>
<end position="184"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="189"/>
<end position="198"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="205"/>
<end position="215"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="220"/>
<end position="223"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="230"/>
<end position="245"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="249"/>
<end position="256"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="261"/>
<end position="263"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="268"/>
<end position="272"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="276"/>
<end position="290"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="297"/>
<end position="300"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="302"/>
<end position="304"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="306"/>
<end position="313"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="318"/>
<end position="322"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="324"/>
<end position="332"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="343"/>
<end position="348"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="349"/>
<end position="354"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="358"/>
<end position="365"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="367"/>
<end position="369"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="376"/>
<end position="383"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="387"/>
<end position="396"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="401"/>
<end position="405"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="411"/>
<end position="414"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="415"/>
<end position="421"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="424"/>
<end position="426"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="427"/>
<end position="437"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="444"/>
<end position="449"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="451"/>
<end position="463"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="468"/>
<end position="471"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="473"/>
<end position="475"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="477"/>
<end position="480"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="482"/>
<end position="488"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="491"/>
<end position="498"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="499"/>
<end position="501"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="502"/>
<end position="504"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="509"/>
<end position="517"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="522"/>
<end position="529"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="535"/>
<end position="537"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="539"/>
<end position="545"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="547"/>
<end position="552"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="553"/>
<end position="562"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="569"/>
<end position="575"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="578"/>
<end position="580"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2I4I"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2JGN"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4PXA"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5E7I"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5E7J"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5E7M"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6O5F"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22223895"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24129315"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q62167"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00541"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00542"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10329544"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10859333"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15294876"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15507209"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16301996"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16818630"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17095540"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17357160"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17667941"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18264132"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18583960"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18596238"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18628297"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18632687"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18636090"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18846110"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19029303"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19913487"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20127681"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20375222"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20657822"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20837705"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21170385"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21589879"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21730191"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21883093"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22034099"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22323517"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22872150"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23413191"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23478265"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26030138"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26100019"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26235985"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27105836"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27546789"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27736973"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27980081"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28128295"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28733330"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28842590"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29062139"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29222110"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29899501"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30131165"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30256975"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30341167"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="31300642"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="31575075"/>
</source>
</evidence>
<evidence key="71" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9381176"/>
</source>
</evidence>
<evidence key="72" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="73" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15294876"/>
</source>
</evidence>
<evidence key="74" type="ECO:0000305"/>
<evidence key="75" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="17667941"/>
</source>
</evidence>
<evidence key="76" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="21883093"/>
</source>
</evidence>
<evidence key="77" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="22872150"/>
</source>
</evidence>
<evidence key="78" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="28733330"/>
</source>
</evidence>
<evidence key="79" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="29062139"/>
</source>
</evidence>
<sequence length="662" mass="73243" checksum="7074D2B8A6EBBF09" modified="2007-01-23" version="3">MSHVAVENALGLDQQFAGLDLNSSDNQSGGSTASKGRYIPPHLRNREATKGFYDKDSSGWSSSKDKDAYSSFGSRSDSRGKSSFFSDRGSGSRGRFDDRGRSDYDGIGSRGDRSGFGKFERGGNSRWCDKSDEDDWSKPLPPSERLEQELFSGGNTGINFEKYDDIPVEATGNNCPPHIESFSDVEMGEIIMGNIELTRYTRPTPVQKHAIPIIKEKRDLMACAQTGSGKTAAFLLPILSQIYSDGPGEALRAMKENGRYGRRKQYPISLVLAPTRELAVQIYEEARKFSYRSRVRPCVVYGGADIGQQIRDLERGCHLLVATPGRLVDMMERGKIGLDFCKYLVLDEADRMLDMGFEPQIRRIVEQDTMPPKGVRHTMMFSATFPKEIQMLARDFLDEYIFLAVGRVGSTSENITQKVVWVEESDKRSFLLDLLNATGKDSLTLVFVETKKGADSLEDFLYHEGYACTSIHGDRSQRDREEALHQFRSGKSPILVATAVAARGLDISNVKHVINFDLPSDIEEYVHRIGRTGRVGNLGLATSFFNERNINITKDLLDLLVEAKQEVPSWLENMAYEHHYKGSSRGRSKSSRFSGGFGARDYRQSSGASSSSFSSSRASSSRSGGGGHGSSRGFGGGGYGGFYNSDGYGGNYNSQGVDWWGN</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

